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ABSTRACT 
 Staphylococcus pseudintermedius is a major opportunistic canine pathogen that has been 
associated with an increasing number of human infections. As an opportunist, S. pseudintermedius 
causes a wide range of infections, predominantly of skin and soft tissue but also device/implant 
related infections and systemic infections such as bacteremia. Increasing methicillin and multiple-
drug-resistance in the species complicate treatment of S. pseudintermedius infections, which are 
often already difficult to treat due to the bacteria’s ability to produce biofilms that hamper effective 
use of antimicrobial drugs. Biofilm formation and virulence factor expression in Staphylococcus 
is regulated, in part, by the accessory gene regulator (agr) operon. Polymorphisms in this operon 
result in four distinct agr groups (I, II, III, and IV) in S. pseudintermedius. In S. aureus, agr groups 
are associated with infection type, virulence factor carriage, and phylogenetic relationships. This 
operon has shown promise as a therapeutic target in S. aureus. Similar relationships remain largely 
unexplored in S. pseudintermedius. Furthermore, the pathogenic differences in infections caused 
by S. pseudintermedius between canines and humans and the characterization of isolates causing 
human infections in general are substantively lacking. Biofilm characterization was performed on 
710 clinical isolates from healthy and diseased canines. We found that the majority of clinical 
isolates from dogs produce biofilm, while a type of biofilm utilizing slime was found to be 
associated with isolates causing disease. In order to explore the associations of agr groups of S. 
pseudintermedius, whole-genome-sequencing was performed on 160 isolates collected from four 
groups (pyoderma infections, surgical infections, urinary tract infections, and healthy 
colonization). We found that agr group II isolates were significantly associated with healthy 
colonization rather than disease, and were less likely to be multiple-drug-resistant or carry multiple 
toxin genes. The predominant methicillin-resistant sequence types were identified for the 
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geographic region (Texas) including ST64, St68, ST71, ST84, ST150, and ST155. Four isolates 
from human bacteremia infections and four from canine bacteremia infections were sequenced and 
complete, or near-complete, genome assemblies were achieved and published, allowing for the 
examination and comparison of virulence factors associated with both human and canine invasive 
infections. While statistical significance was not seen with the small sample size, pan-genomic 
analysis did allow us to identify genes unique to the isolates causing human infections. 
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CHAPTER I 
INTRODUCTION 
Background 
In Staphylococcus pseudintermedius very little is known about the agr groups and their 
associations with virulence factors, types of infection, and phylogenetic relationships. The 
complex nature of biofilm regulation and its association with infection and colonization of healthy 
animals requires further investigation; whether biofilm formation is associated with agr group, as 
the agr operon is known to influence biofilm dispersion, is unknown.  Staphylococcus 
pseudintermedius is increasingly being found in human infections; the characterization of such 
isolates and investigation into whether there are phenotypic or genetic pathogenic differences 
between isolates infecting these two species are needed. To address these questions, the 
dissertation is divided into 3 aims, each comprising a chapter of the dissertation. 
Specific Aims 
AIM 1: Measure biofilm forming capabilities of 710 S. pseudintermedius isolates collected 
from canines presenting with and without clinical disease to the Texas A&M University Veterinary 
Medical Teaching Hospital (VMTH), and classify them based on biofilm production. 
AIM 2: Complete whole-genome sequencing and assembly of 160 clinical isolates. 
Determine the agr type of 160 isolates collected from dogs presenting with surgical infections, 
pyoderma, urinary tract infections, and healthy dogs that presented to the VMTH. Determine the 
1 
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multi locus sequence type (MLST) of all clinical isolates sequenced. Determine whether agr type 
is associated with disease type, MLST, or biofilm production. 
AIM 3: Complete whole-genome assembly of 8 bacteremia isolates (four canine and four 
human) using a combination of long- and short-read sequencing technologies. Determine whether 
there are any describable differences between canine or human isolates regarding agr type, MLST, 
and virulence factors. 
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CHAPTER II 
LITERATURE REVIEW 
 
Overview of Staphylococcus pseudintermedius 
Staphylococcus species are well known both as commensal bacteria and as significant 
pathogens in humans and animals. These gram-positive, nonmotile bacteria cause infections 
ranging from mild skin infections to bacteremia, necrotizing pneumonia, and toxic shock. As 
antibiotic resistance spreads, challenges to both human and animal health are increasing. In 2017, 
following the emergence of vancomycin -intermediate and -resistant strains, the World Health 
Organization labeled methicillin-resistant Staphylococcus aureus (MRSA) as a high-priority 
pathogen. In the past twenty years, health care-associated infections, especially infective 
endocarditis and prosthetic device infections, have been increasing alongside an epidemic of 
community-associated skin and soft tissue infections caused by drug resistant strains of S. aureus 
(163). Concurrently, Staphylococcus infection and antimicrobial resistance in animal species is 
increasing, posing concerns not only for the health of our pets and livestock, but for increased 
treatment costs and potential human infections (95, 136). Staphylococcus pseudintermedius is a 
coagulase-positive, opportunistic pathogen that colonizes many different species of animals and is 
a major pathogen in dogs. It is the primary cause of canine pyoderma and the culprit of a wide 
range of infections, including bacteremia, device-related, and post-surgical infections. Increasing 
resistance to antimicrobial agents has been observed, with methicillin-resistant S. 
pseudintermedius (MRSP) becoming a widespread challenge to antimicrobial treatments.  While 
rare, human infections caused by S. pseudintermedius have been observed and, as bacterial 
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identification methods improve, more isolates are being identified as agents of human infection, 
including those previously misidentified as S. aureus (14, 21, 85, 94, 143, 156, 187, 188). 
 
Population Structure 
Staphylococcus pseudintermedius is part of the normal flora of dogs. It is a commensal that 
is cultured at high frequencies from the nares, oropharynx, and perineum of dogs. Cutaneous 
microbiome analysis shows this species is present in low numbers at most body sites in all dogs 
tested and constitutes 90% of staphylococci isolated from healthy carriers and from dogs with 
underlying skin disease (46, 61, 67). The majority of dogs appear to be persistent carriers, and such 
carriage is associated with higher numbers of S. pseudintermedius at the colonization sites (9, 68). 
The genetic diversity of strains isolated from different anatomical sites of the same dog is high 
(12, 46, 68, 128, 129, 139). This diversity is lower in dogs afflicted with atopic dermatitis, where 
isolates from different body sites are more likely to be related or identical using pulsed-field gel 
electrophoresis (PFGE) (46). In dogs with infected lesions of atopic dermatitis, superficial 
pyoderma, or otitis externa, the majority of the isolates from infection sites are either closely 
related or identical to isolates found in the mucosa (46, 128, 139), suggesting a link between 
colonization and infection similar to that seen in humans with S. aureus (182).  
Unlike Staphylococcus aureus, the population structure of S. pseudintermedius is 
extremely heterogeneous. There is a great variability of PFGE patterns observed in isolates from 
both healthy and diseased dogs (46, 124). Over the past decade, methicillin-resistant and multi-
drug resistant strains have emerged worldwide through the horizontal transfer of resistance 
plasmids into successful methicillin-susceptible S. pseudintermedius (MSSP) lineages, forming 
large MRSP clonal complexes (CCs) that dominate specific geographic regions (45). These MRSP 
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lineages are an exception to the otherwise high diversity of S. pseudintermedius isolates, although 
significant diversity has been discovered within the CCs (151). 
 
Multi Locus Sequence Typing 
Multi locus sequence typing (MLST) is the predominant DNA sequenced-based technique 
used for analysis of population structure and epidemiological trends of S. pseudintermedius 
worldwide. Prior to 2005, any non-pigmented, coagulase-positive, hemolytic staphylococci 
isolated from dogs were considered Staphylococcus intermedius, which included staphylococci 
colonizing a wide range of animals including dogs, horses, skunks, weasels, raccoons, bears, 
minks, camels, and pigeons (66). High diversity within S. intermedius led investigators to 
hypothesize multiple species were being categorized together; after thirty years, S. intermedius 
was determined to be made up of three distinct species: Staphylococcus delphini (which can further 
be divided into groups A and B), Staphylococcus intermedius, and Staphylococcus 
pseudintermedius; known collectively as the Staphylococcus intermedius group (SIG) (8, 42, 140). 
In 2007, Bannoehr et al., proposed the first 5-loci MLST scheme for SIG isolates, which 
determined two major MRSP clones at that time: ST68 in North America and ST71 in Europe 
(126). In 2013, Solyman et al., published the first species specific MLST scheme, consisting of 7 
genes, for S. pseudintermedius with a publicly available database on the online Bacterial Isolate 
Genome Sequence Database (BIGSdb) genomics platform 
(http://pubmlst.org/spseudintermedius/) (151).  
In 2016, a comprehensive review of published, sequence-typed S. pseudintermedius 
isolates determined that MRSP represented 76% (n = 1087) of isolates characterized by the 7-gene 
MLST scheme and found high genotypic diversity among isolates (130). The high representation 
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demonstrates reporting bias toward MRSP isolates, which are more clinically relevant yet make 
up a minority of S. pseudintermedius isolates. The Pires dos Santos review found that MRSP 
isolates are associated with a variety of different sequence types (STs) that are often clustered with 
the more genetically heterogeneous MSSP STs. The major group and subgroup founders (ST45, 
ST68, ST112, ST258, etc.) appeared as distinct phylogenetic lineages that do not share a recent 
common ancestor and were categorized into CC including the founder and single, double, and 
triple locus variants. At the time of the review, the majority of reported MRSP isolates were 
recovered from Europe (70.6%), followed by 22.4% from Asia and only 6.2% from North 
America. The most widely disseminated clone was found to be ST71, which successfully spread 
across 14 countries in 3 continents. CC71 and CC258 were most frequently found in Europe (93% 
and 98% respectively), while CC68 was the most common complex in North America (66.7%) 
and CC45 and CC112 were the most common in Asia (59.5% and 48.9% respectively).      
Ribosomal MLST (rMLST) examines the allelic variation in 53 ribosomal genes to type 
any genus and species of bacteria. Most Staphylococcus spp. contain two copies of the rpsN and 
rpmG genes from this scheme, which are consequently excluded for typing (n = 51 genes for 
Staphylococcus rMLST) (79, 105). This is a newer method of typing than MLST, and there are 
limited rMLST reported for S. pseudintermedius in BIGSdb, with some predominant rMLST 
correlating with major ST; rMLST 17490 (ST71), 17491 (ST68), and 48490 (ST84). 
 
Commensal to Pathogen: Virulence Regulation 
Regulatory systems 
Staphylococcus pseudintermedius is a commensal colonizer of most dogs and does not act 
as a pathogen until the resistance of its host is lowered and the skin barrier impacted, often by 
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predisposing factors (e.g. atopic dermatitis, immunosuppressive disorders, and medical or surgical 
procedures) (180). Staphylococcus pseudintermedius virulence is tightly regulated by several 
systems in order to coordinate the shift from commensal to pathogen. One of the main regulatory 
quorum sensing systems of Staphylococcus virulence is the accessory gene regulatory system 
(agr). While this is not the only regulatory system in Staphylococcus species, agr is considered a 
main global regulator of virulence. It regulates over 70 genes, many of which have been shown to 
be virulence factors, as well as directly impacting several other global regulators (55).  
In S. aureus, the agr system not only has direct effects on virulence through activation and 
repression of toxins and cell adhesion molecules, as will be described in the next section, but also 
indirect effects by interacting with other regulatory systems. The mRNA effector molecule of agr, 
RNAIII, directly binds to the rot global regulator and results in the upregulation of exoproteases, 
lipase, urease, enterotoxins, leukocidins, alpha-toxins, methicillin resistance, and downregulation 
of protein A and oligopeptide permease among other surface proteins (19, 134). SarR and SarS are 
regulators that repress certain virulence genes, and RNAIII binds to several Sar proteins and acts 
as an anti-repressor (5). RNAIII also represses spa, which codes for the surface protein A, and 
mediates the inhibition of translation and the degradation of stable spa mRNA by RNase III. In a 
similar dual action manner, RNAIII binds to the mRNA of coa, which codes for staphylocoagulase, 
a virulence factor promoting the clotting of human plasma, and represses the synthesis of the 
molecule as well as degrading the mRNA (28). The mgrA global regulator in S. aureus affects over 
350 genes involved in virulence, including antibiotic resistance, autolysis, and biofilm formation; 
RNAIII binds to and stabilizes the regulatory molecule of this system (65). This list is hardly 
exhaustive; S. aureus has at least 16 two-component regulatory systems identified so far, with 
many interactions between them. Furthermore, these regulatory systems respond to a wide range 
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of environmental stimuli, including oxidative stress, host serum, nutrient availability, iron, 
glucose, and hemoglobin (74, 106, 116, 135, 144, 159, 190). As a result, gene regulation in 
Staphylococcal species consists of a multitude of overlapping and interacting feedback networks 
(5). The agr system is perhaps the most well understood and one of the few that has also been well 
defined in S. pseudintermedius. It is also the focus for most therapeutic intervention studies 
targeting quorum sensing systems in S. aureus, which suggests it has potential as a therapeutic 
intervention in S. pseudintermedius as well. 
 
The accessory gene regulator system 
The agr locus generates two divergent primary transcripts, RNAII and RNAIII, which are 
transcribed in opposite directions under the control of the P2 and P3 promoters, respectively. The 
P2 promoter directly controls the transcription of four proteins necessary for the quorum sensing 
mechanism: AgrA, AgrB, AgrC, and AgrD, while P3 controls the transcription of genes affecting 
virulence. The system is summarized in Figure 1. 
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Figure 1: The agr System 
 
The two-component agr quorum sensing system. The agr operon encodes the AgrD propeptide, the AgrB transmembrane protein 
which removes the AgrD C-terminus and cyclizes the peptide into a lactone ring structure called the autoinducing peptide (AIP), 
the AgrC transmembrane sensor kinase which is autophosphorylated in response to binding by AIP, and the response regulator 
AgrA which acts at promoters P2 and P3 to induce transcription of RNAII and RNAIII which regulates biofilm formation and 
virulence factors. 
 
 
 
The AgrD propeptide consist of 45 amino acids and is the precursor of the final AIP. The 
propeptide consists of the N-terminal amphipathic leader, a center 7-12 amino acid region that will 
form the final AIP molecule, and a C-terminal region. The N-terminal leader localizes the 
propeptide to the cytoplasmic membrane, where the transmembrane protein AgrB will remove the 
C-terminal tail and cyclize the remaining peptide. In S. aureus, the AIP region contains 8-9 amino 
acids, with a cysteine in the 5th position from the carboxyl terminal and will form a thiolactone 
ring structured AIP (109). In S. pseudintermedius, the AIP region contains 9 amino acids with a 
5th position serine, resulting in a lactone ring structured AIP (29). Following cyclization, the AgrD 
peptide is released from AgrB, transported to the outer face of the cellular membrane, and the N-
terminal is removed by type I signal peptidase SpsB to form the final AIP (84). At sufficient 
density, the AIP molecule is detected by the receptor kinase AgrC (98). Receptor binding of AIP 
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results in autophosphorylation of AgrC, which activates the response regulator AgrA via trans-
phosphorylation. AgrA forms a phosphorylated homodimer to induce the transcription of P2 and 
P3, with a higher affinity for P2 (54, 88). 
The P3 promoter controls the upregulation of secreted virulence factors and down 
regulation of surface proteins, such as protein A encoded by spa, via RNAIII (148). RNAIII also 
acts as a messenger RNA and encodes the hld gene for delta-toxin (δ-haemolysin) as well as 
increasing the production of proteases and capsule synthesis (75, 76, 113, 114). 
In S. aureus, the agr operon positively regulates various toxins and virulence factors while 
negatively regulating surface proteins and consequently enhancing biofilm detachment. The agr 
system is activated by AIP during the transition from exponential growth to the stationary phase. 
During the initial stage of infection, cell density is low and the agr system is repressed, allowing 
the production of adhesive cell surface proteins to promote colonization. This repression of the 
system is necessary for biofilm formation, and enhanced adhesion is seen in mutants with 
nonfunctional agr systems (173). As the cellular density increases, AIP production passes the 
threshold and activates the agr system, resulting in the production of exoproteins and membrane-
damaging toxins that aid in biofilm detachment, spread, and upregulation of bacterial cells (20, 93, 
173). 
 
Autoinducing peptides: alleles of agrD 
Polymorphisms in the AIP region of AgrD and corresponding regions of the AgrB and 
AgrC proteins have resulted in the classification of different agr groups in staphylococcal species. 
Four AIP allelic variants have been identified in S. aureus with many more identified in other 
staphylococci species. Four variants (I – IV), distinct from those of other Staphylococcus species, 
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have been identified in S. pseudintermedius (8, 159). The four agr groups of S. aureus demonstrate 
competitive inhibition to AgrC binding (54, 78, 118). Similar cross-inhibition and cross-activation 
has been demonstrated in other species of Staphylococcus, as well as between different species, 
suggesting that these interactions may be involved with niche competition and colonization (90, 
120). 
Two hypotheses for agr diversity have been proposed. The first suggests that agr 
interference may result in isolated bacterial populations due to decreased genetic exchange, niche 
competition, and evolutionary diversification; this is supported by the frequent association of the 
agr alleles with specific genotypes. The second hypothesis suggests that agr diversity may result 
in QS systems with differing signaling properties and consequent virulence regulation, supported 
by the fact that there are differences in the timing and magnitude of P3 signal generation and 
unique cell density response points for the four agr alleles in S. aureus dependent on the variability 
of the agrBDCA genes (54).  
In Staphylococcus pseudintermedius, four unique agr alleles have been identified, as 
shown in Figure 2: RIPTSTGFF (I), RIPISTGFF (II), KIPTSTGFF (III), and KYPTSTGFF (IV) 
(8, 159). Relationships between these four agr types, types of infections, and virulence factor 
carriage are poorly understood in this species. Further, while inter- and intra-species cross 
interference effects have been shown to exist with agr alleles of S. aureus and S. epidermidis, these 
have not been well examined for S. pseudintermedius agr alleles. Downregulation of S. aureus 
RNAIII by S. pseudintermedius AIP-containing supernatant has been observed, but the agr groups 
of these isolates were unknown (24). 
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Figure 2: S. pseudintermedius AIP Peptides  
 
S. pseudintermedius has 4 unique agrD alleles resulting in 4 distinct, lactone-ring structured autoinducing peptides. 
 
 
 
 
Virulence Factors 
Biofilms and adhesion molecules 
One of the major virulence factors in staphylococci is the ability to form biofilms: layers 
of densely packed cells embedded in an extracellular matrix of secreted polysaccharide 
intercellular adhesion (PIA), proteins, and DNA that allow the bacteria to adhere to surfaces, 
including implanted devices and catheters. Bacterial cells embedded in biofilms benefit from 
enhanced antimicrobial resistance, potentially due to decreased metabolic activity and cell 
division, both of which are targets of many antibiotics (32). Bacteria embedded in biofilms can 
withstand antibiotic concentrations up to 1000-fold higher than their planktonic counterparts (26) 
and have a higher resistance to host immune responses and chemotherapies (96, 123). As 80% of 
chronic bacterial infections are biofilm associated, this is a major clinical concern (39). In fact, 
there is almost a direct correlation between the emergence of S. epidermidis as a pathogen and its 
biofilm-dependent capacity to colonize indwelling medical devices (172). Disrupting biofilms in 
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S. aureus re-sensitizes MRSA to β-lactam antibiotics, an important step to improving treatment of 
these infections (191). While biofilm formation is less well-characterized in S. pseudintermedius, 
recent studies have shown that the majority of S. pseudintermedius isolates from canine infections 
are able to produce biofilms (150, 155). 
Staphylococcal biofilms initially form through adherence of the bacterial cells to a biotic 
or abiotic surface followed by growth-dependent accumulation of cells. This results in multiple 
layers of bacterial cells embedded in a slime matrix. Initial attachment often involves the secretion 
of PIA, which is a main component of the slime matrix. PIA-producing isolates are known as 
slime-forming isolates. The production and secretion of PIA is controlled by the icaADBC operon, 
and mutations in the operon result in inability or reduced capacity to form biofilms in both S. 
aureus and S. epidermidis (35, 69). This operon is tightly regulated, and co-expression of icaA and 
icaD results in increased PIA production (2). These genes are found in a majority of staphylococcal 
isolates; in S. pseudintermedius, icaA and icaD homologs are found in 78% and 91%, respectively, 
of isolates examined (25, 150).  
PIA-independent biofilms also exist in staphylococcal species and there are many other 
important biofilm molecules, including autolysins (Atl and AtlE), accumulative-associated protein 
(Aap), biofilm associated protein (Bap), and Bap homologue protein (Bhp) that offer alternative, 
non-PIA associated mechanisms for biofilm formation in S. aureus and S. epidermidis (30, 36, 47, 
51, 164). The most prevalent group of surface proteins that are involved in staphylococcal adhesion 
are known as microbial surface component recognizing adhesive matrix molecules 
(MSCRAMMs), consisting of two adjacent IgG-folded domains that allow them to adhere to 
components of the host’s extracellular matrix, which is crucial not only for biofilm formation, but 
also for the invasion of host cells (100, 112). MSCRAMMS of S. pseudintermedius are less well 
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characterized than those in S. aureus; the S. pseudintermedius surface proteins A-R (SpsA-SpsR) 
are a collection of predicted cell-wall-anchored surface proteins. SpsD and SpsL (homologous to 
S. aureus FnBPA and FnBPB) adhere to fibrinogen, fibronectin, and, for SpsD, cytokeratin and 
are expressed during infection. Further, SpsD, SpsL, and SpsO are known to mediate adherence to 
canine corneocytes (9). In 2016, a comparative study reported S. pseudintermedius as the only 
staphylococcal species that significantly adheres to human fibronectin and invades the human 
osteosarcoma-derived MG-63 cell line with higher rates than S. aureus, mediated through SpsD 
and SpsL (103, 127). 
 
Biofilm regulation 
Staphylococcal biofilms have a complex system of regulation that is impacted by agr and 
other global transcriptional regulators, including the staphylococcal accessory regulator (sarA), as 
well as environmental cues. Similarly, biofilm dissemination involves active mechanisms to return 
bacteria to a planktonic state, using both environmental cues and multiple regulatory systems. 
The exact nature of the relationship between agr and biofilm is complex. This relationship 
has been most comprehensively studied in S. aureus, but there is significant conflict in the 
literature. In some strains (RN6390B), biofilms can only be formed after agr has been deleted or 
suppressed (13, 166), while in other strains agr is required. Staphylococcus aureus’s glucose-
induced biofilm formation is downregulated by agr when grown on polystyrene plates (173), but 
agr was found to both promote and inhibit glucose-induced biofilm on polystyrene in another study 
(31). When the level of AIP signal is artificially controlled, researchers found that the entire 
biofilm could be dispersed in both S. aureus and S. epidermidis (20, 175). The agr system is 
generally considered necessary for biofilm dispersal, allowing the bacteria to spread to new sites 
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during an infection; close examination of S. aureus biofilms show pockets with activated agr 
systems, resulting in regions of the biofilm with active cells leaving the biofilm to colonize a new 
site (175, 189).  Additionally, bacteria dispersing from biofilms show high levels of agr activity, 
while bacteria embedded in biofilms show repressed agr systems (189). This is due in part to agr 
activation resulting in the transcription of proteases important to biofilm dispersal and inhibition 
(20).  
 
Antimicrobial resistance 
Methicillin and β-lactam Resistance: Methicillin was introduced in 1960 to treat infections 
caused by Gram-positive bacteria that produced beta-lactamase or penicillinase, an enzyme that 
rendered penicillin inactive. The first methicillin-resistant S. aureus was identified in 1961. 
Because of significant side effects of therapy with methicillin such as interstitial nephritis, 
alternatives were developed and methicillin has been replaced by other drugs, however the 
description “methicillin-resistant” has remained in use to describe resistance to all penicillin-
family drugs. Resistance is conveyed by mecA, which codes for alternative penicillin-binding 
protein PBP2a and is located on the mobile genetic element (MGE) staphylococcal cassette 
chromosome mec (SCCmec), and blaZ, encoding a β-lactamase that can be carried on a plasmid 
or chromosomally integrated. Both of these resistance genes can be horizontally transferred 
between species of Staphylococcus (180). Prior to 1999, the reported frequency of MRSP in canine 
isolates was under 5% (59). The first mecA positive strain was reported in a canine isolate from 
the US in 1999 (59) and has since been increasingly reported worldwide and recognized as a 
serious health problem (81, 180). There are a limited number of MRSP clones spread worldwide, 
similar to the distribution and dissemination of MRSA (62). MRSP is widespread, and many, if 
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not the majority, of MRSP isolates are multiple-drug-resistant (MDR) (56, 57, 181), with 
resistance in nearly all classes of antibiotics and often mediated by resistance genes carried by 
MGE (82). There has been an increasing trend of resistance to penicillinase-labile penicillins since 
the 1980s in MSSP, likely as a result of the spread of blaZ (111). Cephalosporin remains one of 
the only classes of β-lactams for which no resistance genes have been seen (181). 
Tetracyclines: Tetracyclines (including doxycycline, minocycline, and tigecycline) 
function by inhibiting protein synthesis by reversibly binding to the 30S ribosomal subunit and 
preventing the attachment of aminoacyl-tRNA to the ribosomal acceptor site. There are several 
tetracycline resistance genes (tet genes) found in bacteria, which function as either efflux pumps 
or as ribosomal protection, and the majority are associated with conjugative or mobile genetic 
elements. In Staphylococcus, tet(K) and tet(L) code for efflux pumps while tet(M) and tet(O) code 
for ribosome protective proteins, with tet(M) and tet(K) being the most common (82, 126). The 
tet(M) gene confers resistance to all tetracyclines (16) while tet(K) does not confer minocycline 
resistance; one study found 26% of isolates were doxycycline resistant but minocycline 
susceptible, with 69% of MRSP isolates susceptible to minocycline (179). 
Macrolides, Lincosamides, and Streptogramins (MLS): Macrolides (including 
erythromycin, roxithromycin, azithromycin, and clarithromycin) act by inhibiting protein 
synthesis via binding to the 50S ribosomal unit with a variety of targets and efficiency. 
Lincosamides and streptogramins both bind to the 23S area of the 50S bacterial ribosomal subunit, 
interfering with protein synthesis and consequently preventing replication. In S. pseudintermedius, 
mrs(A) acts as an ABC transporter that can export macrolides and streptogramin B antibiotics 
while erm(A), erm(B), and erm(C) encode rRNA methylases conferring resistance to macrolides, 
lincosamides, and streptogramin B antibiotics. The erm(B) gene is most common, and tends to be 
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constitutively expressed (58, 126). The Inu(A) gene in S. pseudintermedius codes for a lincosamide 
nucelotidyl-trasnferase, which is less common and often carried with erm(B). These genes are 
often carried on MGE. 
Chloramphenicol: A bacteriostatic antimicrobial, chloramphenicol inhibits protein 
synthesis by binding to the 23S rRNA of the 50S ribosomal subunit and preventing peptidyl 
transferase activity. Resistance to chloramphenicol is less common, but still clinically relevant in 
S. pseudintermedius, where catpC221 is the most common resistance gene, encoding a 
chloramphenicol acetyltransferase that is carried on 3-4 kb plasmids (60, 145, 146). 
Aminoglycosides: Aminoglycosides inhibit protein synthesis by binding to the 30S 
ribosomal subunit in bacteria. In S. pseudintermedius, ant(6’)-Ia encodes a streptomycin 
adenyltransferase that is encoded on plasmids and found chromosomally integrated and conveys 
resistance to streptomycin (18), while aac(6’)-Ie-aph(2’)-Ia encodes an aminoglycoside 
acetyltransferase and is found on MGE. Another common aminoglycoside resistance gene is 
aph(3’)-III, which is a transposon encoded aminoglycoside phosphotransferase. Frequency of each 
of these resistance mechanisms varies with one study finding that 75% (24/32) of amikacin 
resistant isolates carried aph(3’)-IIIa followed by aac(6’)/aph(2”) in 12% (4/32) of isolates and 
ant(4’)-Ia in 3% (1/32) of isolates (57). 
Trimethoprim: Binding to dihydrofolate reductase, trimethoprim inhibits bacterial DNA 
synthesis by preventing the synthesis of thymidine. The gene dfrG is often carried on a plasmid 
and encodes a dihydrofolate reductase that is resistant to trimethoprim binding. This resistance 
gene is frequently seen in MRSP isolates (126). 
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Other Resistances: This summarizes the most common resistances in S. pseudintermedius 
that will be examined in the following chapters, but resistance to fluoroquinolones, rifampicin, 
mupirocin, and others are also seen in this species (6, 41, 56, 107, 126, 142). 
 
Toxins 
Staphylococcal species have a plethora of toxins that fall into three main groups: 
exfoliative, membrane damaging, and superantigens. In S. aureus, these toxin genes can be 
horizontally transferred between Staphylococcus isolates and species and are often found on large 
MGE including pathogenicity islands, integrated prophages, or plasmids (1). Staphylococcus 
pseudintermedius infections in both canines and humans are often severe as a consequence of 
tissue necrosis (178). Isolates show virulent behavior on non-professional phagocytic cells 
including invasion, persistence, and cytotoxicity in canine keratinocytes, human epithelial cells 
and human osteoblasts (102, 127).  Secreted virulence factors including delta-toxin and Luk-I 
leukocidin induce cytotoxic effects, although fewer toxins have been identified and confirmed 
compared to S. aureus (102). 
Exfoliative Toxins: The staphylococcal exfoliative toxins consist of secreted serine 
proteases that may facilitate infection by cleaving the cell-to-cell adhesion molecule desmoglein 
(Dsg-1) in the skin (77). These toxins are involved in cutaneous infections in mammals, such as 
bullous impetigo and staphylococcal scaled-skin syndrome. Four exfoliative toxins have been 
identified in S. pseudintermedius, but their potential for horizontal gene transfer is undetermined. 
The speta toxin gene is found almost universally among S. pseudintermedius isolates (10, 15, 34). 
Of similarly high carriage is the siet toxin (10, 15, 33, 34), which has also been found to induce 
cell rounding in cultured epithelial cells (161). The clinical impact and biological relevance of this 
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toxin is still under dispute, as dogs injected with SIET developed clinical signs similar to pyoderma 
in one study (161), while a later study found no such effects (72). The last two exfoliative toxin 
genes, expA and expB, have more variable carriage (15). Formerly exi, the expA gene encodes the 
toxin EXPA, found to cause intraepidermal splitting in mouse and canine skin (52, 72). Similarly, 
the EXPB toxin was found to cause intraepidermal splitting and degradation of Dsg-1 in beagle 
dogs (73).  
Membrane Damaging Toxins: Several staphylococcal toxins, including α-hemolysin, 
leukocidins, and phenol-soluble modulins are pore-forming, causing damage to the cellular 
membrane of host cells that leads to cellular lysis and tissue necrosis (63).  Leukocidins in S. 
aureus are associated with recurrent soft tissue infections and necrotizing pneumonia, contribute 
to immune system evasion by lysing a variety of immune cells, and are generally encoded on 
prophage (63). In S. pseudintermedius, the bicomponent Luk-I leukocidin, encoded by lukS and 
lukF, is found in the vast majority of isolates and displays high cytotoxicity for polymorphonuclear 
neutrophils (131). Recent research suggests this toxin exhibits a tropism for myeloid cells 
expressing the CXCR2 receptor (102). Delta-toxin, encoded by hld, is a phenol-soluble modulin 
found in the vast majority of strains that may act as a surfactant and limit the aggregation of cells 
into a biofilm (173). It is secreted at high levels by clinical strains in vitro and is cytotoxic to non-
professional phagocytic cells (specifically osteoblasts) in a dose-dependent manner (102). The 
phenol-soluble modulin PSMε is similarly highly represented, secreted, and cytotoxic to 
osteoblasts (102). In contrast, BacSp222 is a bacteriocin-like toxin that has been found only rarely 
in S. pseudintermedius and that lyses other Gram-positive bacteria (184). 
Superantigens: Superantigens indiscriminately stimulate T-lymphocytes through the 
activation of major histocompatibility complex class II molecules, bypassing the need for antigen 
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presentation and resulting in a flood of cytokines. This cytokine storm can cause shock and organ 
failure in hosts. Two possible enterotoxin superantigens have been identified in S. 
pseudintermedius: seccanine and se-int (44, 53). While the clinical importance of se-int remains 
unknown, seccanine has been shown to induce vomiting and T-cell proliferation (44, 70). 
 
Virulence profiles of clonal complexes 
The major clonal complexes of MRSP display differences in virulence gene carriage 
patterns, with some CCs displaying conserved virulence gene profiles (CC45) while others show 
higher diversity (CC71 and CC258), suggesting that the distribution of resistance and toxin genes 
are correlated both with clonal spread as well as horizontal gene transfer within this species (126, 
181). While antibiotic resistance profiles have been well examined in the three largest CC (CC45, 
CC71, and CC258), profiles of other CC have not displayed significance or have not been well 
examined. Toxin gene carriage and biofilm formation within clonal complexes have also not been 
well established. 
Isolates of ST71 generally display high resistance; a multicenter study found that 74% of 
MRSP isolates belonged to ST71, and of those 87% were resistant to at least 6 classes of 
antimicrobials (126). ST71 isolates typically carry tet(K) if they demonstrate doxycycline 
resistance, while tet(M) is rarely seen in this group. In contrast, non-CC71 lineages were 
significantly associated with carriage of tet(M) alone (130). Tetracycline resistance overall was 
lower in CC71 than isolates of CC258 and CC45 (130). One study found 15 different resistance 
patterns within isolates of this CC, and additionally determined ST71 to be the most likely to 
demonstrate discrepancies between antimicrobial resistant genotypes and phenotypes (181). CC71 
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isolates were also found to produce significantly more biofilm compared with the other major 
groups (117). 
Isolates of CC258 were found to display fewer resistance patterns with high variability 
(126). Isolates of ST258 generally show lower prevalence of resistance to gentamicin and 
enrofloxacin compared to the other groups, and have a higher prevalence of resistance to 
trimethoprim and sulfamethoxazole (130). Chloramphenicol and tetracycline resistance were also 
lower within this CC (130).  
In contrast to CC258 and CC71, strains in CC45 display a very conserved pattern of 
resistance gene carriage of ant(6’)-Ia,  aac(6’)-Ie-aph(2’)-Ia, aph(3’)-III, ermB, dfrG, tet(M), 
catPc221, blaZ, and mecA. Consequently, CC45 isolates show remarkably higher prevalence of 
resistance to chloramphenicol (95%) compared with either CC71 (43%) or CC258 (13%) (130). 
Few other CC have been studied for virulence profiles; CC68 generally demonstrates resistance to 
doxycycline, minocycline, and tetracycline via carriage of tet(M) (126).  
 
Cross-Interference of the agr System and Therapeutic Potential 
            With the increasing difficulty of treating highly-resistant staphylococcal infections, the 
manipulation of quorum sensing systems has become a promising area of therapeutics (86). The 
cross-inhibiting AIPs of Staphylococcus species offer a natural reservoir of molecules to test for 
potential clinical use. The agr groups are often defined by mutual inhibition, within and between 
species that results in a unique type of competition and bacterial interference where the agr regulon 
is blocked by binding of a competing AIP rather than induced (78). This is especially relevant for 
species that frequently co-inhabit environments, such as S. aureus and S. epidermidis on the human 
skin; all S. aureus groups are sensitive to inhibition by the S. epidermidis AIPs, except for S. aureus 
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agr group IV, which is also the only group able to inhibit the S. epidermidis agr system in return. 
The impact of this competition has been suggested as the reason for why S. epidermidis 
predominates over S. aureus on human skin (118). A more recent study found that the AIP 
molecules of 37/52 staphylococcal isolates representing 17 different species could inhibit S. aureus 
agr, with S. schleiferi AIP molecules the most potent inhibitors against all 4 agr groups of S. 
aureus. When these AIPs were synthetically recreated, they could completely abolish agr 
induction of S. aureus (24).  
The ability to understand and exploit this natural avenue of competition is apparent when 
the effects are demonstrated in vivo. When S. schleiferi and S. aureus species were injected into 
moth larvae in a co-colonization competition, the expression of S. aureus virulence factors was 
suppressed and the infection was far less severe, with a significant increase in survival (24). 
Directly inhibiting the agr system has been found to block abscess formation (185), decrease skin 
lesion size and halt the progression of skin infections (38, 109), and improve host defenses in 
murine models (38, 158). In a mouse model of inflammatory skin disease mimicking atopic 
dermatitis, an agr-inhibitor molecule resulted in reduced production of delta-toxin (an important 
virulence factor impacting cutaneous inflammation) and decreased skin inflammation (7). In 
contrast to antimicrobial treatments, no induction of resistance or tolerance has been seen in this 
approach (158).  
No studies on cross-inhibition or virulence attenuation have been performed with the four 
S. pseudintermedius AIPs and S. pseudintermedius infections.  
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Human Infections of S. pseudintermedius 
    While humans have not been recognized as a typical host for S. pseudintermedius and any 
colonization is often transient, nasal passage colonization of humans can occur for prolonged 
periods (50, 168). Transmission between dogs and owners is possible, and has been reported more 
frequently with veterinary staff having a higher prevalence of S. pseudintermedius colonization 
than the general population (40, 50, 64, 67, 104, 140, 160, 168). Several studies have confirmed 
that the isolates carried by veterinary staff or dog owners are the same as those found on the dogs 
(8, 50, 64, 124, 152, 167). This suggests S. pseudintermedius is a zoonotic pathogen, however 
cases of apparent human-to-human infection have been described in a Swedish hospital (154) and 
recent studies on human colonization and infections have discovered that the association with dogs 
in human cases is as low as 10% (94, 188). In 2010, a case of human-human transmission through 
a saliva contaminated syringe resulting in skin abscesses was also documented (85). 
One of the major complications of recognizing S. pseudintermedius as a human pathogen 
has been the underreporting of cases due to frequent misidentification of S. pseudintermedius as 
S. aureus.  Until recently, S. pseudintermedius was not included in the databases of commercial 
identification systems (169) and similarities in morphology and biochemical characteristics 
resulted in rates of misdiagnosis ranging from 13% (21) to 21% (188). These errors are 
significantly reduced when species identification is performed with matrix-assisted laser 
desorption and time-of-flight mass spectrometry (MALDI-TOF) (188). Accurate identification is 
key because the cefoxitin surrogate for methicillin-resistance testing in S. aureus often fails to 
detect methicillin-resistance in S. pseudintermedius (14, 143, 187).  Misidentification of S. 
pseudintermedius can therefore complicate treatment of human infections.  
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Staphylococcus pseudintermedius is most frequently associated with skin and soft tissue 
infections as well as animal bite wounds, but can cause a wide range of infections in humans 
including bacteremia, otitis externa, cardiomyopathy, and endocarditis (21, 152, 169). A Canadian 
study of 24 cases found the median age of patients to be 61 with a 75% majority of the cases being 
a skin/soft tissue infection. Of the 17 isolates cultured from these cases, 6 were MRSP and MDR 
and belonged to ST71 and ST181; the remainder were MSSP of varying STs (152).  The pattern 
of a majority of human clinical isolates being MSSP is reflected in several other studies, where 
1/13 (21), 12/80 (188), and 0/4 were found to be MRSP (101), resulting in the majority of human 
isolates attributed to new STs rather than the major MRSP CCs. One study examined toxin carriage 
in 13 S. pseudintermedius isolates that had been misdiagnosed as S. aureus and found universal 
carriage of LukS/F-I, siet, and se-int and low carriage of expA (2/13) and expB (1/13) (21). Many 
infections occur in patients who are diabetic or immunocompromised (152, 188).  
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CHAPTER III 
BIOFILM FORMATION AND PHENOTYPIC CHARACTERIZATION OF CLINICAL 
ISOLATES1 
 
Introduction 
Biofilm formation is an important component of Staphylococcus virulence, allowing the 
pathogen to colonize surfaces of implants, catheters, and other medical devices. The vast majority 
of tested S. pseudintermedius isolates are biofilm formers, with 96% producing moderate to strong 
biofilms (25, 150). A vital component of biofilm formation is the ability of bacteria to produce 
slime (PIA) resulting in a viscous extracellular polysaccharide layer (35, 69). The purpose of this 
study was to phenotypically characterize the biofilm forming capabilities of our S. 
pseudintermedius collection (n = 710) through testing for slime production and overall biofilm 
production. We hypothesized that most isolates would be biofilm and slime producing, and that 
there would be a difference in slime production and overall biofilm production between diseased 
and healthy dogs.  
 Slime production can be qualitatively determined using the Congo red biofilm assay 
(CRA): Congo red dye binds to polysaccharides secreted by colonies growing on plates containing 
the dye along with sucrose to encourage biofilm formation. Slime producing colonies will turn 
black to indicate secretion of polysaccharides, while non-slime forming colonies will remain red. 
This assay is often implemented as a quick screening method for large numbers of 
isolates.  However, as biofilms produced by Staphylococcus can be protein based and form without 
 
1 Reprinted with permission from Little SV, Bryan LK, Hillhouse AE, Cohen ND, Lawhon SD. 2019. 
Characterization of agr groups of Staphylococcus pseudintermedius isolates from dogs in Texas. mSphere 
4. Copyright 2019 Little et al. Creative Commons 4.0 International License. 
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the extracellular polysaccharide layer (115), this assay can result in false negatives for biofilm 
production. Furthermore, the evaluation is qualitative and variation in the literature on positive and 
negatives suggest this test is not the most reliable; for a quantitative measure of overall biofilm 
production, the crystal violet microtiter plate test (CVA) has been employed (87, 108). This assay 
uses crystal violet, a dye which is most commonly known for its use in Gram staining, which binds 
to peptidoglycans and sugar-containing molecules, including DNA. By growing the bacteria under 
biofilm-inducing conditions, carefully rinsing non-adherent cells, dying adhered cells and biofilm, 
and then resuspending the dye and measuring the optical density, a quantitative measure on overall 
biofilm production can be obtained.  
  
Materials and Methods 
Bacterial isolates and demographics 
Staphylococcus pseudintermedius strains collected between 2007 and 2016 were acquired 
from the clinical microbiology lab of a referral veterinary hospital, post-species identification. 
Isolates were collected from canine patients, both healthy (n = 182) and diseased (n = 528), and 
stored in glycerol lysogeny broth (LB) at -80°C at the time of isolation. Diseased isolates were 
residual patient diagnostic samples collected from canines with various conditions and culture 
sources, of which skin (n = 319) and urine (n = 81) were the most common. Healthy isolates were 
collected for a staphylococcal screening study by culturing the nares and perineal skin of 
dermatologically healthy canines attending evaluations for orthopedic surgery. All sampling 
conformed to the ethical guidelines and standards of care for the hospital. The Institutional Animal 
Care and Use Committee and Clinical Research Review Committee approved the collection of 
isolates from the healthy dog group (AUP 2010-068).  
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For this study, plate cultures were grown on trypticase soy agar (TSA) with 5% sheep blood 
(blood agar; BBL, USA) and incubated aerobically at 37°C for 24 hours. Liquid cultures were 
made by single-colony inoculation of tryptic soy broth (TSB; BD, USA) incubated aerobically and 
shaken overnight.  ATCC S. epidermidis strain 12228 and ATCC S. aureus strain 25923 were used 
as negative and positive controls, respectively, for biofilm production. 
  
Phenotypic characterization of slime production by Congo red assay 
 To assess isolate ability to produce slime as characterized by polysaccharide intercellular 
adhesin (PIA) production, isolates were cultured on Congo red agar plates. Plates were prepared 
as previously described (2, 4). In brief, 37 g brain heart infusion broth (BHIB; BD, USA), 13.5 g 
agar (Teknova, USA), 36 g sucrose (VWR, USA), and 0.8 g Congo red (VWR, USA) per 1 L of 
media was autoclaved for 15 minutes at 121°C and poured into plates. After inoculation, plates 
were incubated at 37°C for 24 hours, brought to room temperature, assessed, photographed, and 
then left to incubate overnight at room temperature and assessed again at 48 hours. Slime 
production was determined by the color and texture of the colony surface based on a 5-point scale 
system adjusted from Aricola, et al.:  smooth, very red (0), red (1) and bordeaux (3) colonies are 
non-slime-producing, and rough, almost black (4) and black (5) colonies are slime-producing (2, 
4). This scale and a plate example are visualized in Figure 3. It should be noted that some negative 
strains (including ATCC 12228) may produce a black coloration on the surrounding agar while 
the colonies themselves are red. Plates were grown in biological and technical duplicate. 
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Figure 3: Congo Red Assay  
 
The Congo Red Assay utilized a 5-point scale (A) where, from left to right, smooth, very red colonies (0), smooth, red colonies 
(1), and bordeaux colonies (2) were negative for slime production, and rough almost black (3) and black (4) colonies were 
positive. An example of a technical duplicate of the plates at two time points (B) demonstrates the qualitative nature of the assay. 
 
 
 
 
Phenotypical characterization of biofilm production by crystal violet microtiter plate assay 
Overall biofilm production was assessed by the ability of the isolates to adhere to a 96-
well, polystyrene microtiter plate (Nunc-Immuno, USA), using protocols adjusted from 
Stepanović et al. (157). Cultures were grown on blood agar plates for 24 hours at 37°C and single 
colonies were then transferred to deep well plates containing 1 mL of TSB. Liquid cultures were 
grown, shaken, overnight at 37°C. Cultures were then diluted 1:200 in TSB containing 1% glucose 
(Mallinckrodt Chemicals, USA) to encourage biofilm production in flat bottomed, non-tissue 
culture treated microtiter plates. Following 24 hours of incubation at 37°C, the suspension cultures 
were removed and wells gently washed with ddH2O to remove non-adherent cells. Adherent cells 
and biofilm were stained with 0.1% crystal violet dye per well for 15 minutes. The excess dye was 
removed, wells rinsed with ion-free water, and the plate allowed to air dry. Biofilm-bound dye was 
resuspended in 95% ethanol (Koptec, Decon Labs, USA) and the absorbance of each well read at 
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OD570. The values of each plate were adjusted by subtracting the average of the blank control 
wells (TSB broth only). Cutoffs for biofilm production was established using a previously 
established 4-point scale (157), where 0 is non-adherent (OD ≤ ODcontrol), 1 is weakly adherent 
(ODcontrol < OD ≤ 2*ODcontrol), 2 is moderately adherent (2*ODcontrol < OD ≤ 4*ODcontrol), and 3 is 
strongly adherent (4*ODcontrol < OD). Microtiter plate assays were performed in technical and 
biological triplicate. 
 
Statistical analyses 
    All analyses for the biofilm characterization study were performed using SAS software. To 
assess for relationships between disease status and biofilm, the isolates were categorized as 
diseased or healthy. Slime production was categorized as slime-producing (1) or non-slime 
producing (0). Overall biofilm production was categorized as 0, 1, 2, or 3 (corresponding to the 
grading scale of non-adherent, weakly adherent, moderately adherent, and strongly adherent). 
These categorical variables were compared using chi-squared or Fisher’s exact test when expected 
cells had counts fewer than 5. A P value less than 0.05 was considered significant.  
 
Results 
Biofilm assays were performed on clinical isolates (n = 710) from unique dogs (Table 1). 
Slime-production, as determined by CRA, was found in approximately half of the isolates (51%, 
n = 362). The proportion of slime-producing isolates in diseased dogs (55%, 291/528) was 
significantly (P = 0.0002) greater than that of isolates from healthy dogs (39%, 71/182) (Figure 4). 
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Table 1: Biofilm Assay Results  
 CRA 
Negative 
Non-Slime 
Producing 
CRA 
Positive 
Slime 
Producing 
CVA 0 
Non-
Adherent 
CVA 1 
Weakly 
Adherent 
CVA 2  
Moderately 
Adherent 
CVA 4 
Strongly 
Adherent 
Total Collection (n = 710) 
Total 348 
49% 
362 
51% 
83 
12% 
240 
34% 
313 
44% 
74 
10% 
Healthy 111 
32% 
71 
20% 
9 
11% 
53 
22% 
98 
31% 
22 
30% 
Diseased 237 
68% 
291 
80% 
74 
89% 
187 
78% 
215 
69% 
52 
70% 
CRA 
Negative 
- - 37 
45% 
118 
49% 
154 
49% 
39 
53% 
CRA 
Positive 
- - 46 
55% 
122 
51% 
159 
51% 
35 
47% 
Percentages have been rounded and may not total to 100%.  
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Figure 4: Biofilm Production of Clinical Isolates 
 
Results of biofilm assays on the 710 clinical isolates from diseased dogs and healthy dogs. The proportion of slime 
producing dogs was significantly higher (*) in diseased dogs than healthy dogs.  
 
 
 
The CVA ODcontrol was 0.3317 (±0.1818). Overall biofilm production, measured by CVA, 
showed a majority of isolates (78%, 553/710) produced weak or moderate biofilms. Eighty-three 
isolates (12%) were non-adherent while only 74 (10%) were strongly adherent. There was no 
significant difference in the distribution of overall biofilm production between slime-producing 
and non-slime-producing isolates. Overall biofilm production differed significantly between 
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healthy and diseased sourced isolates (P = 0.0014), which was largely attributable to a high 
proportion of non-adherent isolates in the diseased category. 
There was no significant association between overall biofilm production measured by CVA 
and slime production as measured by CRA, with similar distributions of CVA scores between CRA 
negative and positive isolates.  
 
Discussion 
Slime-production was only seen in half of isolates, which is lower than expected (25). 
Slime production occurred in a significantly higher proportion in isolates from diseased dogs than 
isolates from healthy colonization, perhaps highlighting the importance of slime in clinical disease. 
However, the Congo red test has several drawbacks; in part, it underestimates the total biofilm-
producing capability in Staphylococcus spp. due to PIA-independent biofilms and highly variable 
induction conditions. The genes required for slime production in Staphylococcus, icaA and icaD 
in particular, are nearly universal across isolates and yet we do not see slime production in all 
isolates using the standard Congo red protocol. This phenomenon has been widely acknowledged 
across literature in S. aureus, supporting sensitive and varied growth conditions required for slime 
production (25, 35, 170). Furthermore, there is variation in the color of the single ATCC strain 
negative control across literature even with identical culture conditions (27, 71, 83, 192, 194). As 
such, the scale in this study was altered to include bordeaux colonies as negative for slime 
production rather than intermediate, as dark red and bordeaux colonies of ATCC 12228 and 
negative controls are seen both in literature (27, 71, 83, 192, 194) and in this study (Figure 5), even 
when conditions were matched to those studies that produced bright red colonies.  
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Figure 5: Negative Slime Control Color Variation 
 
Congo red plate results for the negative control strain ATCC 12228 compared to a positive strain under 
varying plate compositions. The standard dye and sucrose concentration are indicated by red (0.08% CR, 3.6% 
sucrose), at which concentrations ATCC 12228 grows dark red colonies on a black plate discoloration. 
 
 
 
Consequently, while Congo red is useful for quick, large-scale characterization, more 
weight is given to CVA as an accurate measure of biofilm production (87, 108). According to 
CVA, the majority of the isolates (88%) were biofilm producers, which agrees with the current 
literature on biofilm production in Staphylococcus clinical isolates and highlights the importance 
of biofilm formation for the colonization of Staphylococcus (136, 155).  
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CHAPTER IV 
ASSOCIATIONS BETWEEN DISEASE TYPE, VIRULENCE FACTORS, MLST, AND AGR 
GROUP2 
 
 Introduction 
While associations between agr type and infection type have been found in S. aureus and 
S. epidermidis, no such associations have been thoroughly investigated in S. pseudintermedius. 
Four known agr AIPs have been found unique to S. pseudintermedius, consisting of 9 amino acids 
containing a serine at position 5 and processed to form a lactone ring between that serine and the 
terminal end (RIPTSTGFF (I), RIPISTGFF (II), KIPTSTGFF (III), KYPTSTGFF(IV)). The 
purpose of this study was to determine the agr type of 160 clinical isolates from 4 different 
infection source groups (healthy dogs, urinary tract infections, surgical infections, and pyoderma) 
and examine the relationship(s) between agr type, infection, MLST, and virulence factors such as 
biofilm formation, antimicrobial resistance gene carriage, and toxin genes. We hypothesized that 
there would be associations between infection source and agr type as well as virulence factors and 
agr type. Due to the clonal nature of MRSP, we also hypothesized that there would be associations 
between MLST and virulence factors and agr type, despite the horizontal transfer of virulence 
factors on MGEs. 
  
 
 
 
2 Reprinted with permission from Little SV, Bryan LK, Hillhouse AE, Cohen ND, Lawhon SD. 2019. 
Characterization of agr groups of Staphylococcus pseudintermedius isolates from dogs in Texas. mSphere 
4. Copyright 2019 Little et al. Creative Commons 4.0 International License. 
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Materials and Methods 
Bacterial isolates and demographics 
Out of the 710 clinical isolates described in Chapter III, 40 were randomly selected from 
the disease groups pyoderma, urinary tract infection, and healthy colonization. The number was 
limited to 40 due to availability of surgical infection isolates in the collection (n = 40), all of which 
were included, resulting in a total of 160 isolates sequenced for this analysis.  
  
DNA extraction, library preparation, and sequencing 
Isolates were grown from source freezer stock on blood TSA for 24h at 37ºC and 
subcultured twice. A single colony was inoculated into brain, heart infusion broth and grown for 
8 hours and 1 mL inoculum was used for DNA extraction via MasterPure™ Gram Positive DNA 
Purification Kit, (Epicentre, Lucigen, USA) per their standard protocol. DNA was quantified using 
the Life Technologies Qubit high sensitivity dsDNA assay and all samples were normalized to 100 
ng of DNA in a total volume of 14 ul. Sequencing libraries were prepared by hand using the Bioo 
Scientific NEXTflex Rapid DNA-Seq Kit per their standard protocol. Prepared libraries were 
checked with the Qubit high sensitivity dsDNA assay to determine concentration and the Agilent 
TapeStation D1000 HS to determine the average fragment size of the prepared libraries. All 
samples were normalized to 4 nM and pooled together for sequencing. The 4 nM pool was diluted 
to 20 pM and sequenced on the Illumina MiSeq 300 x 300 cycle v3 sequencing kit. All run data 
and FASTQ files were uploaded to BaseSpace (Illumina) for downstream analysis. 
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Genome assembly and annotation 
The Illumina MiSeq reads were assembled using SPAdes de novo genome assembly 
(version 3.6.2) on the Texas A&M Institute for Genome Sciences and Society (TIGSS) computing 
cluster, with the following parameter: --careful. The resulting assemblies were annotated using the 
Rapid Annotation using Subsystem Technology tool kit (RASTtk) on the Pathosystems Resource 
Integration Center (PATRIC) (177).  
  
Typing agr 
In order to determine agr group, BLAST was used on the assembled genomes using 
previously published sequences for the four agrD alleles (GenBank EU157356.1, EU157391.1, 
EU157400.1, and EU157402.1). In the case of alleles that did not match the four published types, 
the sequence was checked in the original reads and then the agrD sequences were extracted and 
purified for Sanger sequencing by Eton Bioscience using PCR primers previously published for 
agrBD (29).  
 
Virulence factors 
Biofilm production and slime production were measured as described in Chapter III. 
Carriage of icaA and icaD, genes essential to PIA/slime production, was checked by PATRIC’s 
BLASTP, searching for genomic features using previously published primers (150). BLAST was 
similarly used to identify toxin carriage of known S. pseudintermedius toxin genes (speta (UniProt 
ADX77621), siet (UniProt CAR57917.1), expA (UniProt BAI49625.1), expB (UniProt 
BAJ23893.1), Luk-S/F (131), sec-canine (44), se-int (53), BacSp222 (184). ResFinder 2.1 (August 
2018, 193) was used to check for antimicrobial gene carriage for the following antimicrobial 
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resistance gene categories: aminoglycoside; β-lactam, colistin; fluoroquinolone; fosfomycin; 
fusidic acid; glycopeptide; macrolide, lincosamide, and streptogramins (MLS); nitroimidazole; 
oxazolidinone; phenicol; rifampicin; sulphonamide; tetracycline; and trimethoprim. The presence 
or lack of mecA (UniProt B1GVE2) was confirmed by BLAST.  
  
MLST 
Multilocus sequence typing was performed using the 7-gene (tuf, cpn60, pta, purA, fdh, 
sar, ack) MLST scheme (MLST-7) utilized by the Staphylococcus pseudintermedius MLST 
database (https://pubmlst.org/spseudintermedius/; curator Vincent Perreten) (151). Potential new 
alleles were identified in our genomes via BLASTP and the FASTA sequences submitted to the 
database for allelic determination and final ST assignment.  Grouping of isolates into CC was 
performed using the PHYLOViZ analysis (49), including all S. pseudintermedius isolates 
deposited in the database as of August 2018. Due to a lack of resolution in MLST-7, a 53-gene 
ribosomal multilocus sequence typing (rMLST) method was also used to type the isolates, utilizing 
the database curated by Keith Jolley (https://pubmlst.org/rmlst/) (79). 
 
Statistical analyses 
All analyses for the biofilm characterization study were performed using SAS software. 
Significant associations were assessed using chi-squared or Fisher’s exact test when expected cells 
had counts fewer than 5. Data were analyzed using contingency tables (k x k, as indicated for the 
specific comparison: some tables were 2 x 2 layouts, whereas others had more than dichotomous 
levels).  Significance for analysis was set at P < 0.05.  
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Results 
Prevalence and distribution of agr groups 
All but two S. pseudintermedius WGS isolates had 100% identity to one of the four known 
agrD alleles. One exception contained a silent mutation in the AIP region, the other contained a 
missense mutation in the C-terminus region resulting in a lysine instead of glutamic acid. As 
neither of these mutations impact the final AIP protein structure, they were categorized 
accordingly. 
Eleven isolates (7%) were classified as agr group I, 50 (31%) as agr group II, 44 (28%) as 
agr group III, and 55 (34%) as agr group IV.  
 
 
 
Table 2: WGS Biofilm Assay Results 
 CRA 
Negative 
Non-Slime 
Producing 
CRA 
Positive 
Slime 
Producing 
CVA 0 
Non-
Adherent 
CVA 1 
Weakly 
Adherent 
CVA 2  
Moderately 
Adherent 
CVA 4 
Strongly 
Adherent 
Sequenced Isolates (WGS, n = 160) 
Total 77 
48% 
83 
52% 
17 
11% 
58 
36% 
72 
45% 
13 
8% 
Healthy 23 
30% 
17 
20% 
2 
12% 
15 
26% 
21 
29% 
2 
15% 
Pyoderma 19 
25% 
21 
25% 
3 
18% 
12 
21% 
18 
25% 
7 
54% 
Urinary 
Tract 
15 
19% 
25 
30% 
4 
24% 
18 
31% 
14 
19% 
4 
31% 
Surgical 20 
26% 
20 
24% 
8 
47% 
13 
22% 
19 
26% 
0 
0% 
CRA 
Negative 
- - 10 
59% 
28 
48% 
33 
46% 
6 
46% 
CRA 
positive 
- - 7 
41% 
30 
52% 
39 
54% 
7 
54% 
MRSP 16 
21% 
36 
43% 
9 
53% 
15 
26% 
23 
32% 
5 
38% 
MSSP 61 
79% 
47 
57% 
8 
47% 
43 
74% 
49 
68% 
8 
62% 
Biofilm assay results. Percentages have been rounded and may not total to 100%. Adapted from Little et al. 2019 
(99). 
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Biofilm production 
Biofilm results for the 160 WGS isolates are given in Table 2 (99). Approximately half of 
the isolates were slime-producing and there was no significant association of slime production as 
measured by CRA with the disease groups or methicillin resistance as determined by presence of 
mecA. For overall biofilm formation as determined by CVA, a majority of isolates formed biofilms 
(89%; 143/160), of which most (91%; 130/143) were weak to moderate. No significant 
associations were seen between overall biofilm production and disease group, slime-production, 
or methicillin resistance. Slime-production was significantly less associated with agr II and III 
compared to agr I and IV (P = 0.0415, Figure 6, A). There was no significant difference between 
overall biofilm production in the four agr groups (Figure 6, B). 
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Figure 6: Biofilm Production by agr Group 
 
Slime-production (A) and overall biofilm production (B) across agr groups. Slime production was significantly less 
associated with groups II and III (A).  
 
 
 
The majority (98%; 156/160) of isolates carried both icaA and icaD for PIA/slime 
production. Of the four that did not, one was slime positive and formed a moderate biofilm, one 
was slime positive and formed a strong biofilm, one was slime negative and formed a moderate 
biofilm, and one was negative for both slime and biofilm production.  
  
Disease associations of agr groups 
The distribution of agr groups differed significantly between healthy and diseased dogs (P 
= 0.025) Figure 7. Group II isolates were significantly more common in healthy dogs than diseased 
dogs (P = 0.0058). No further significant associations were seen between agr groups and disease 
and the disease groups of healthy, pyoderma, urinary tract, or surgical infections. 
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Figure 7: The agr Distribution of Disease Groups 
 
The distribution of agr groups across the four disease groups. Group II was significantly more common in isolates 
from healthy colonization.  
 
 
 
Resistance gene carriage of agr groups 
Resistance gene carriage across agr groups is described in Table 3. The majority of WGS 
isolates were methicillin-susceptible (68%; n = 108/160) as determined by the lack of mecA. 
Methicillin resistance was identified for 45% (n = 5) of agr group I isolates, 18% of group II (n = 
9), 34% of group III (n = 15), and 42% of group IV (n = 23). Group II isolates were significantly 
(P = 0.0025) less likely to be MRSP. Isolates from healthy dogs were significantly (P = 0.0002) 
less likely to carry mecA than disease isolates. The mecA cassette was found in 8% of healthy 
isolates (n = 3), 48% of pyoderma isolates (n = 19), 30% of urinary isolates (n = 12), and 45% of 
surgical isolates (n = 18). There was a slightly significant difference in distribution of MRSP 
among the three diseased groups, with urinary tract infections being less likely to be MRSP than 
pyoderma and surgical infections (P = 0.0471). 
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Sixty-four isolates carried genes for aminoglycoside resistances (aac(6')-aph(2''), ant(6)-
la, or aph(3')-III), but there was no significant association between agr types and aminoglycoside 
resistance. There was a significant association between agr groups and macrolide, lincosamide, 
and streptogramin (MLS) resistance gene carriage (erm(B) and inu(A)), with the proportion of 
gene carriage significantly less in agr group II isolates (P = 0.0171). Similarly, the proportion of 
tetracycline resistance carriage (tet(K) and tet(M)) was significantly (P = 0.0057) less in group II. 
For trimethoprim resistance, the proportion of isolates that carried the resistance gene dfrG among 
agr groups III or IV was significantly (P = 0.0005) higher than that for isolates of groups I or II. 
There was no association seen between agr group and β-lactam resistance gene carriage, as most 
isolates (n = 139) carried blaZ. No association was seen between agr group and chloramphenicol 
resistance, as most isolates (n = 152) did not carry cat(pC221). 
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Table 3: Virulence Factor Carriage Across agr Groups 
 agr Group 
I 
n = 11 
agr Group 
II 
n = 50 
agr Group 
III 
n = 44 
agr Group 
IV 
n = 55 
Toxin Gene Carriage 
expA 0% 8% 9% 22% ** 
expB 27% 20% 7% * 4% * 
sec – canine 0% * 2% * 14% 16% 
speta 100% 100% 100% 100% 
siet  100% 100% 100% 100% 
luk – S/F 100% 100% 100% 100% 
se – int  100% 100% 100% 100% 
Antimicrobial Resistance and Gene Carriage 
mecA 45% 18% * 34% 42% 
Aminoglycoside 45% 34% 32% 51% 
Beta-lactam 82% 84% 82% 95% 
Chloramphenicol 0% 4% 9% 4% 
MLS 45% 18% * 34% 45% 
Tetracycline 55% 36% * 61% 69% 
Trimethoprim 9% * 12% * 32% 44% 
MDR 45% 16% * 34% 47% 
Virulence factor carriage. * indicates agr group is significantly less likely to carry, ** indicates agr group 
is significantly more likely to carry. 
 
 
 
There was a significant association between agr group and multiple-drug-resistance 
(MDR) as defined by resistance to three of the five classes of antibiotics other than β-lactams. 
Group II isolates were significantly (P = 0.0045) less likely to be MDR and groups II or III were 
significantly (P = 0.0052) less likely to be MDR than groups I or IV.  
Only 16 isolates were susceptible to all drug classes. Of these, 2 (13%) were agr group I, 
7 (44%) were agr group II, 6 (38%) were agr group III, and 1 (6%) was agr group IV. 
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Toxin carriage of agr groups 
Toxin carriage is summarized in Table 3. There was universal carriage of the speta, siet, 
luk-S/F, and se-int toxin genes. Twenty isolates carried expA and 17 carried expB, with 1 isolate 
carrying both genes. Relative to the other agr groups, agr group IV isolates were significantly 
more (P = 0.0199) likely to carry expA. The overall distribution of agr groups by expB carriage 
also differed significantly, as isolates of agr groups III and IV were significantly less (P = 0.0037) 
likely to carry expB than isolates of groups I and II. Sixteen isolates carried sec-canine, with agr 
groups III and IV being significantly more (P = 0.0126) likely to carry sec-canine than groups I 
and II. Finally, one isolate carried the gene for the bacteriocin-like peptide BacSp222. 
 
 
Figure 8: Phylogenetic Relationships of North American Isolates 
 
PHYLOViZ (goeBURST) visualization of genetically related groups and their founders through 7-gene 
MLST as of August 2018. Dark blue indicates the isolates from our lab, including the 160 WGS study, light blue 
indicates other North American isolates, grey indicates non-North American isolates. Node size is linearly related to 
the number of isolates of that ST submitted to PubMLST S. pseudintermedius database. All isolates in the database 
are included in (A), with the major founder groups circled in red as follows: 84 (B), 45 (C), 71 (D), and 68 (E).is 
significantly more likely to carry.  
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Phylogenetic relationships and clonal complexes based on MLST 
MLST determined 91 new allele combinations, 31 new alleles, and 113 new strain types 
submitted to the S. pseudintermedius pubMLST database. PHYLOViZ analysis (49) in August 
2018 suggested the major S. pseudintermedius clonal complexes (CC) represented in this study 
and in all submitted North American isolates to be CCs 45, 64, 68, 71, 84, 150, and 155 (Figure 
8). The highest represented STs in our isolates were STs 64, 68, 71, 84, 150, and 155. Significant 
associations were seen between ST64 and agr group II (P = 0.012, 5/5 isolates were agr II), 
between ST68 and agr IV (P < 0.0001, 13/13), between ST71 and agr III (P = 0.0005, 7/7), and 
between ST 84 and agr I (P < 0.0001, 5/5); ST150 and ST155 had too few isolates (n = 3 each) to 
see significance, but all members were agr group IV. Characteristics of these groups are 
summarized in Table 4. 
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Table 4: Characteristics of Major MLST Groups 
MLST agr Type 
 
Disease 
Group 
Slime 
Formation 
Overall Biofilm 
Production 
Drug Resistances Toxin 
Carriage 
64  
(n = 5) 
5 agr II * 1 Healthy  
2 Pyoderma 
1 Urine 
1 Surgical 
2 Slime 
Forming 
 
3 Non-Slime 
Forming 
0 Non-Adherent 
3 Weakly 
Adherent 
2 Moderately   
    Adherent 
0 Strongly  
    Adherent 
5 mecA (MRSP)* 
5 Aminoglycoside* 
5 Beta-lactam* 
2 Macrolide* 
3 Tetracycline* 
1 Trimethoprim* 
1 MDR* 
0 expA 
0 expB 
0 sec-
canine 
68  
(n = 13) 
13 agr 
IV* 
0 Healthy 
2 Pyoderma 
6 Urine 
5 Surgical 
11 Slime 
Forming 
 
2 Non-Slime 
Forming 
3 Non-Adherent 
3 Weakly 
Adherent 
6 Moderately  
    Adherent 
1 Strongly 
    Adherent 
 
13 mecA (MRSP)* 
13 Aminoglycoside* 
13 Beta-lactam* 
13 Macrolide* 
13 Tetracycline* 
13 Trimethoprim* 
13 MDR* 
0 expA 
0 expB 
0 sec-
canine 
71 
(n = 7) 
7 agr III* 0 Healthy  
1 Pyoderma 
1 Urine 
5 Surgical* 
1 Slime 
Forming 
 
6 Non-Slime 
Forming 
4 Non-Adherent* 
0 Weakly 
Adherent 
3 Moderately  
    Adherent 
0 Strongly 
    Adherent 
6 mecA (MRSP)* 
7 Aminoglycoside* 
7 Beta-lactam* 
7 Macrolide* 
4 Tetracycline* 
7 Trimethoprim* 
7 MDR* 
0 expA 
0 expB 
0 sec-
canine 
84  
(n = 5) 
5 agr I* 0 Healthy  
2 Pyoderma 
1 Urine 
2 Surgical 
5 Slime 
Forming 
 
0 Non-Slime 
Forming 
1 Non-Adherent 
2 Weakly 
Adherent 
1 Moderately  
    Adherent 
1 Strongly 
    Adherent 
5 mecA (MRSP)* 
5 Aminoglycoside* 
5 Beta-lactam* 
5 Macrolide* 
4 Tetracycline* 
1 Trimethoprim* 
5 MDR* 
0 expA 
1 expB 
0 sec-
canine 
150  
(n = 3) 
3 agr IV 1 Healthy  
2 Pyoderma 
0 Urine 
0 Surgical 
2 Slime 
Forming 
 
0 Non-Slime 
Forming 
0 Non-Adherent 
3 Weakly 
Adherent 
0 Moderately  
    Adherent 
0 Strongly  
    Adherent 
 
3 mecA (MRSP)* 
3 Aminoglycoside* 
3 Beta-lactam* 
2 Macrolide* 
3 Tetracycline* 
3 Trimethoprim* 
3 MDR* 
0 expA 
0 expB 
3 sec-
canine* 
155  
(n = 3) 
3 agr IV 1 Healthy  
1 Pyoderma 
0 Urine 
1 Surgical 
3 Slime 
Forming 
 
0 Non-Slime 
Forming 
0 Non-Adherent 
0 Weakly 
Adherent 
3 Moderately  
    Adherent 
0 Strongly 
    Adherent 
0 mecA (MRSP) 
3 Aminoglycoside* 
3 Beta-lactam* 
2 Macrolide* 
3 Tetracycline* 
2 Trimethoprim* 
2 MDR* 
3 expA* 
0 expB 
3 sec-
canine* 
Significance indicated by results in bold marked by *. 
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The proportion of isolates outside of these main STs was significantly lower (P = 0.0162) 
in diseased dogs compared to healthy dogs. ST was significantly associated with surgical 
infections – in particular, ST71 isolates were significantly (P = 0.0111) more likely to be derived 
from surgical cases. STs also differed significantly (P = 0.0014) by slime production, however 
there was no evidence that individual STs were significantly associated with slime production. The 
distribution of overall biofilm production by CVA differed significantly (P = 0.0032) between 
ST71 and the other types, with a higher proportion of isolates being non-adherent. 
ST was significantly associated (P < 0.0001) with MDR, with STs 64, 68, 71, 84, 150, and 
155 being more likely to be MDR than other STs and all but 150 being significantly more (P < 
0.0001) likely to carry mecA than the other types. These STs were also more likely to carry 
resistance genes to aminoglycosides (P < 0.0001), β-lactam (P = 0.0043), MLS (P < 0.0001), 
tetracycline (P = 0.0003), and trimethoprim (P < 0.0001). Overall, MRSP isolates were more likely 
to be MDR (P < 0.001) and ST associated with methicillin-resistance were significantly (P < 
0.0001) associated with MDR. 
For toxin carriage, there was a significant (P = 0.0142) association of ST with expA 
carriage; ST155 isolates were significantly more (P = 0.0017) likely to be expA positive. No 
association was seen with expB carriage, but ST155 and ST150 were significantly more (P = 
0.0017) likely to carry sec-canine. 
Most of the WGS isolates were from unique rMLST groups. The most common rMLST 
was 17491 (n = 9), 8 of which were ST 68. The next most common was 63159 (n = 3) and 63162 
(n = 3). 
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Discussion 
The majority of WGS isolates were biofilm producing (89%), with the majority of those 
being weakly- and moderately- adhering. This is similar to what we saw in Chapter III, agreeing 
with literature showing that the vast majority of S. pseudintermedius clinical isolates are biofilm 
producing (136, 155). Again, slime production was seen in approximately half of the isolates. All 
but four WGS isolates (98%; 156/160) contained the required icaA and icaD genes for PIA 
production, which suggests that, similar to what has been seen in S. aureus, isolates may have the 
ica locus but may still fail to produce slime in vitro due to sensitive growth conditions (25, 35, 
141, 170). These results impress the importance of a combination of phenotypic and genotypic 
methods for examining biofilm formation in S. pseudintermedius.  
The global population structure of S. pseudintermedius has been well examined; a 2016 
review of 58 studies published in the previous decade determined five major MRSP CCs 
worldwide: CC71, CC258, CC68, C45, and CC112 (130). However, the eBURST analysis at that 
time assigned the isolates into only two major (CC71 and CC258) and two minor (CC379 and 
CC75) clonal complexes (130). Our goeBURST analysis of the 1047 isolates present in the S. 
pseudintermedius PubMLST database at the time of this study, including our 160 isolates, 
identified only one major CC comprising all of the major STs: CC258. This suggests that MLST 
lacks the power to separate the groups, a problem also recently observed in S. aureus (37). 
            Worldwide, ST71 is the most predominant MRSP lineage, followed by ST45, ST258, 
ST261, ST112, ST265, ST68, ST169, and ST181 (130). A 2018 study of 190 canine isolates from 
North America determined the region’s major STs to be ST68, ST71, and ST84 (171). While our 
study also identified ST68, ST71, and ST84 as major North American STs, we discovered ST64 
to be similarly highly represented. Unpublished data including an additional 32 sequenced isolates 
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suggests seven major North American STs are represented in our clinical isolates: ST45 (n= 6), 
ST64 (n = 5), ST68 (n = 13), ST71 (n = 7), ST84 (n = 5), ST150 (n = 3), and ST155 (n = 3), which 
is the first time ST45 has been found to be a major ST in the United States. It should be noted that 
this is not representative of North America as a whole, as sample collection was limited to Texas. 
            MRSP STs are known to be associated with virulence factor carriage (multidrug-resistance) 
and agrD alleles; indeed, in the previous 5-gene MLST scheme, agrD was one of the genes used 
to determine ST (8). Each of the major STs identified in this study is associated with a specific agr 
group, highlighting a lack of assortative recombination within these specific ST in our collection. 
While this is a small sample set from which to draw conclusions, this may suggest that, similar to 
S. aureus, radiation preceded clonal diversification and recombination played a lesser role in agr 
distribution (186). 
Biofilm associations are less well understood; previously, ST71 was identified as one of 
the strongest biofilm formers of any MRSP lineage (11). For overall biofilm formation, ST71’s 
distribution of CVA differed significantly from other types, but it was due to a slight majority of 
ST71 isolates being non-adherent while the rest were moderately adherent, in contrast to previous 
studies. Interestingly, ST71 was associated with surgical infections where biofilm and slime 
production may be important, suggesting that the conditions required for ica activation are both 
complex and sensitive, with potential variation between isolates (138). These main groups were 
also all more likely to be multiple drug resistant, highlighting their clinical importance. 
The majority of our clinical isolates belonged to new, unique STs less closely related to the 
main six MRSP STs per goeBURST. These groups were associated with a higher proportion of 
healthy colonization and were less likely to be MDR. Most were MSSP, which is consistent with 
the known lack of clonality among MSSP isolates (17, 171). MSSP represents a lesser studied, but 
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still clinically relevant group that comprises the majority of S. pseudintermedius isolates. Due to 
their lack of clonality and unique STs, associations between MSSP STs and virulence factors are 
difficult to determine, but associations between agr group and infection and virulence profiles can 
still be examined. 
The prevalence of agr groups in our clinical collection is similar to that seen in the only 
other classification of over 100 S. pseudintermedius isolates into agr groups, with agr I being the 
least prevalent group while agr II, III, and IV are similarly distributed at approximately 30% (8). 
Within our collection, agr group II was found to be more highly associated with commensal 
carriage and methicillin susceptibility and less likely to be slime-producing, MDR, or carry expA 
or sec-canine, while being more likely to carry expB.  In contrast, agr groups I and IV were more 
likely to be slime-producing and MDR. Previously, agr III was determined to be more strongly 
associated with MRSP (33) than the other agr groups, but we did not see that in our collection. 
The lack of association with pyoderma, surgical, or urinary tract infections is not necessarily 
indicative of a lack of association of agr group and infections; such associations may be based 
upon severity of infection and other infection types that we were unable to examine in this study. 
We found that healthy dogs are less likely to carry MRSP isolates than diseased, but this 
result is likely in part due to selection bias in the diseased group of dogs, as most dogs are only 
cultured if an infection is not responding to treatment. The surgical disease group was cultured at 
first appearance of problems without any prior treatments, but the urinary tract disease group and 
pyoderma disease group were potentially subject to this referral hospital bias. Healthy dogs were 
candidates for orthopedic surgery; while not entirely healthy, they did not present any visible skin 
problems and were cultured without any treatment discrimination. 
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Understanding the clinical associations of agr groups is important as demands for 
alternative methods of treatment grow due to increased antimicrobial resistances. The agr system 
is an alternative target for therapeutics in S. aureus, where inhibition of the agr system has 
demonstrated effects on virulence in vivo including increased survival, blocked abscess formation, 
decreased lesion size, hindered progression of skin infections, and improved host defense in 
murine models (24, 38, 122, 158, 185).  The judicious use of antimicrobials in veterinary practice 
is an attempt to limit the spread of resistances to classes of drug considered important or of last 
resort in human medicine. For this reason, vancomycin is not used in small animals at the 
veterinary hospital from which these isolates were collected. As MRSP resistant to all drugs used 
for canine patients are frequently encountered in our patient population, there is a strong need for 
alternative therapies to treat resistant and pervasive infections. Disruption or interference with the 
quorum sensing system of S. pseudintermedius to reduce virulence is a potential avenue that would 
not apply selective pressures for antibiotic resistance. Furthermore, agrD alleles are known to act 
within and between species as potent agr inhibitors, and those of S. pseudintermedius, while not 
comprehensively examined, have demonstrated effects against S. aureus (24). Examining the 
cross-interference potential of the four S. pseudintermedius AIPs will be important, not only as a 
natural reservoir for potential therapeutics but also to understand the effects of co-colonization and 
potential clinical implications of patients colonized by S. pseudintermedius alongside S. aureus or 
S. epidermidis. 
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CHAPTER V 
COMPLETE WHOLE-GENOME HYBRID ASSEMBLY AND GENOME COMPARISON OF 
CANINE AND HUMAN BACTEREMIA ISOLATES OF S. PSEUDINTERMEDIUS 
 
Introduction 
As of January 2019, there are only seven complete S. pseudintermedius genomes published 
on the National Centre for Biotechnology Information GenBank database (NCBI) (HKU10-03, 
ED99, NA45, 081661, 063228, G3C4, SP79) with 43 scaffolded partials and 90 contig 
submissions - in comparison, Salmonella enterica has 630 complete genomes with almost 3,000 
scaffolded partials and 10,000 contig submissions. The goal of this experiment was to use two 
complementary sequencing techniques in order to try and complete the genomes of 8 S. 
pseudintermedius isolates to contribute to NCBI. The ability of staphylococci to invade the host 
and spread through the body via blood suggests the presence of important virulence factors (43, 
48, 119). For this reason, sequenced isolates collected from patients with bacteremia may help 
future identification of important virulence factors. As S. pseudintermedius has recently been 
acknowledged as a human pathogen in addition to a major canine pathogen, whole genome 
sequencing of isolates from both species may provide valuable insights into the pathogenesis of 
the organism in humans.  
We randomly selected four isolates from canine bacteremia cases to compare to four 
available isolates from human bacteremia cases. Complete genomes of these isolates may provide 
important information regarding potential differences in strains that infect humans. Isolates were 
sequenced using Oxford Nanopore’s MinION technology, a long-read sequencing technology, and 
Illumina MiSeq. Long-read sequencing offers improved resolution of complex regions of the 
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genome (such as repeats or duplications) while short reads provide highly accurate but more 
fragmented region coverage. The accuracy of the MinION sequencing is lower than that of MiSeq, 
with an error rate ranging between 14-30% (133, 165). We compensated for this increased error 
rate with both high coverage levels for the MinION sequencing and by using the more accurate 
MiSeq sequences to correct the genome. In order to determine the best assembly algorithm that is 
bold enough to complete the genome while maintaining accuracy, we assembled the genomes 
through the MinION reads alone, MiSeq reads alone, and utilized two hybrid assembly algorithms 
and assessed the resultant assemblies for completeness.  While we did not expect to see statistically 
significant differences at this sample size, we hypothesized that we would see descriptive 
differences in virulence factor carriage between human and canine isolates and potentially between 
their pan-genomes. 
  
Materials and Methods 
Bacterial isolates 
Four canine bacteremia isolates were selected randomly from bacteremia isolates within 
the previously described clinical isolate collection (Chapter III). Four human bacteremia isolates 
were available to us from a collection of human isolates from the Ronald Reagan UCLA Medical 
Center, Los Angeles, CA and the Centers for Disease Control and Prevention, Atlanta, GA (187). 
The identification of the human isolates was performed according to the standard operating 
procedures of the submitting institutions and further confirmed at a central laboratory via a nucleic-
acid-based assay. All isolates were stored and cultured as previously described in Chapter III. 
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DNA extraction, library preparation, and sequencing 
For Illumina sequencing, a 1 mL aliquot of culture grown in BHIB for 8 hours at 37ºC was 
used for extraction. Samples were lysed in a Qiagen Tissue Lyser set to 30Hz for 30 seconds using 
the Macherey-Nagel Bead Tubes Type B and lysis buffer from the NucleoMag Tissue DNA Kit. 
Following the manual lysis, DNA was isolated following the manufacturer's protocol (Macherey-
Nagel). Genomic DNA quality was verified on a genomic DNA Tapestation run (Agilent) and 
samples were quantified with the Qubit fluorometer. DNA sequencing libraries were prepared 
using the Illumina NexteraDNA Flex Library Preparation Kit following the manufacturer’s 
protocol (Illumina). Libraries were pooled at equimolar concentrations and then sequenced on an 
Illumina MiSeq V2 2x250 sequencing kit. 
For MinION sequencing, DNA was similarly extracted and purified, with the additional 
requirement of the DNA sample being approximately 20 ng/µL or higher concentration and the 
addition of lysostaphin during the lysing incubation. MinION libraries were prepared for 
sequencing on the Oxford Nanopore MinIon following the manufacturer’s protocol for 1D PCR 
Barcoding of Genomic DNA using the SQK-LSK108. Genomic DNA quality was verified on a 
genomic DNA TapeStation run (Agilent) confirming high quality (>60 kb) DNA. Samples were 
quantified using High Sensitivity dsDNA Qubit assays on the Qubit 2.0 fluorometer 
(ThermoFisher). DNA samples were normalized to 22 ng/µL and sheared with a Covaris g-Tube 
to generate a ~8kb DNA fragment. After dA-tailing and adapter ligation, specific barcodes were 
added to each sample by PCR amplification using the NEB LongAMP Taq 2x Master Mix 
following conditions: 1 cycle - denature 3 minutes at 95°, 13 cycles – denature 15 seconds at 95°, 
anneal 15 seconds at 62°, extension for 10 minutes at 65°, then a final extension for 10 minutes at 
65° followed by a 4° hold. After barcoding, all samples were pooled and prepared for loading onto 
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the MinIon Flow Cell. Data collection was performed by the MinKNOW software, utilizing the 
following workflow: NC_48Hr_Sequencing_Run_FLO_MIN106_SQK-LSK108.py. MinION 
sequencing data was basecalled using Albacore Sequencing Pipeline Software version 1.2.4.  
  
Genome assembly and annotation 
    Four separate assemblies for each isolate were made and assessed using Benchmarking 
Universal Single-Copy Orthologs (BUSCO) version 3, which provides a quantitative measure for 
the genome assembly, gene set, and transcriptome completeness (149, 176). BUSCO was run using 
the Firmicutes OrthoDB version 9 dataset. The assemblies were also checked by MLST and 
rMLST to ensure no errors with input reads were made, and to compare gene presence and 
completeness. The original MinION and MiSeq reads were assembled separately and assessed, 
and then two hybrid assembly approaches were made using Unicycler and Canu Polishing as 
described below. 
MinION reads were assembled using Canu version 1.5 (89) with the following parameters: 
stopOnReadQuality=false, minReadLength=500, genomeSize=2.6m, useGrid=false. MiSeq reads 
were assembled using SPAdes as previously described in Chapter III. 
The first hybrid assembly approach utilized Pilon version 1.22 (174) to improve the 
MinION assembly using MiSeq reads. The MinION Canu assembled FASTA file was provided as 
the input draft genome, along with BAM files generated by Bowtie2 (default parameters; 91, 92) 
of the MiSeq reads mapped to the MinION genome. Pilon uses read alignment analysis to 
recognize inconsistencies between the MinION genome and MiSeq reads and will correct single 
bases, small and large indeps, fill gaps, and correct misassemblies and then output an improved 
FASTA assembly. Pilon was run three times, to examine improvement between successive 
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polishing runs. Each subsequent run used the previous Pilon polished assembly genome as input, 
along with the BAM files for MiSeq reads mapped to the input genome.  
The second hybrid assembly utilized the Unicycler 0.4.3 pipeline (183). Unicycler 
functions by assembling the MiSeq reads into a highly accurate ‘assembly graph’ made up of 
contigs and their interconnections. It then incorporates the MinION long reads to find the optimal 
paths through the graph (i.e. constrained scaffolding), therefore producing a completed assembly 
with lower missassembly rates. Unicycler was run in --bold mode for these assemblies, where the 
quality cutoff is reduced to increase the chance of completing the assembly. 
Completed hybrid assemblies were scaffolded using Medusa version 1.6 (22) with three 
input reference genomes: ED99 (GenBank Accession No. CP002478) and the two single-contig 
polished assemblies of 51-092 and 53-060. 
  
Typing and gene carriage 
After assembly, agr type, MLST, and virulence gene carriage were examined as described 
in Chapter III. Ribosomal MLST was determined using the rMLST database 
(https://pubmlst.org/rmlst/) as part of the BIGSdb platform (80). New rMLST alleles were 
submitted for inclusion to the database (curated by Keith Jolley). Phylogenetic relationships of the 
8 isolates based on MLST were visualized using PHYLOViZ as previously described in Chapter 
III. 
 
Genome comparisons and pan-genome analysis 
Pan-genomes for all the isolates, human isolates, and canine isolates separately were 
calculated using Roary version 3.11.2 (121). The input GFF3 files for Roary were generated using 
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Prokka version 1.13.3 (147), with the scaffolded and complete genomes as inputs. Pan-genome 
comparisons were run using querey_pan_genome with set one consisting of the canine isolates and 
set two consisting of the human isolates.  
A Newick phylogeny tree file was generated using the Roary output 
core_gene_alignment.aln file as input for RAxML version 8.2.10 (153), for maximum-likelihood 
based phylogenetic inference. A pan-genome frequency plot, presence and absence matrix against 
phylogenetic tree, and a pie chart visualization of the pan genome were generated using 
roary_plots.py.  
Analysis of the gene_presence_absence.csv file produced by Roary in conjunction with a 
traits file (canine/human, slime production, overall biofilm production, and agr type) was 
conducted using Scoary version 1.6.14 to determine significant associations between accessory 
genes and traits (23).     
Proteome comparisons were generated using PATRIC’s Proteome Comparison Service, 
which performs protein sequenced-based genome comparison using bidirectional BLASTP as 
previously described (177). Protein family analysis was similarly performed using PATRIC’s 
Protein Family Sorter tool to generate clustered heatmaps and to summarize gene pathways. 
 
Results 
Genome assemblies 
Assembly data is described in Table 5. The Illumina MiSeq sequencing resulted in an 
output of paired-end read sets containing approximately 1.5 million reads/isolate of 250 bp 
resulting in approximately 300X coverage. MinION sequencing resulted in an output of read sets 
containing 100 mb to 500 mb per sample, resulting in 40X – 200X coverage. MinION Canu 
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assemblies resulted in the fewest contigs, with two complete, single-contig assemblies (51-092 
and 53-060) and the rest ranging from 5 to 29 contigs. MiSeq assemblies contained far more 
contigs (66 to 111). Unicycler assemblies were intermediate between the two, containing 1 to 58 
contigs, while the Canu + Pilon hybrid assemblies preserved the low contig number from the 
MinION assemblies. Scaffolding using Medusa resulted in genomes with 1 to 16 scaffolds for 
Unicycler assemblies and 1 to 3 scaffolds for the Canu + Pilon polished assemblies. The Canu + 
Pilon polished genomes were consequently the most contiguous. 
In terms of quantitative measures of completeness, BUSCO scores were very low in the 
original MinION assemblies (9.9% to 21.6%), while MiSeq were extremely high (99.5% to 
99.6%). Unicycler assemblies preserved the range of MiSeq BUSCO scores. Pilon polishing the 
MinION assemblies increased the BUSCO score dramatically, with the first run bringing the scores 
to 96.6 - 99.6%. Successive runs of Pilon polishing increased the scores to similar values found in 
Unicycler, with the majority reaching 99.6%. Canu + Pilon BUSCO scores increased until the 
number of fragments reached 0 for all assemblies after the third Pilon run. One genome, 53-063, 
had a 0.1 higher BUSCO score with Canu + Pilon than Unicycler, while 49-044 and 46-057 both 
had lower BUSCO scores for Canu + Pilon assembly versus Unicycler (by 0.8 and 0.3 
respectively).  
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Table 5: Bacteremia Genome Assembly Data 
Assembly Contigs Scaffolds BUSCO MLST 
Completeness 
rMLST 
Completeness 
46_57 
MiSeq 111  99.5% 7/7 51/51 
MinION 13  13.3% 1/7 5/51 
Unicycler 14 2 99.5% 7/7 51/51 
Canu + Pilon 13 2 99.2% 7/7 51/51 
49_44 
MiSeq 96  99.5% 7/7 48/51 
MinION 20  9.9% 0/7 3/51 
Unicycler 31 7 99.5% 7/7 51/51 
Canu + Pilon 20 1 98.7% 7/7 51/51 
50_21 
MiSeq 66  99.6% 7/7 51/51 
MinION 7  16.8% 1/7 8/51 
Unicycler 11 1 99.6% 7/7 51/51 
Canu + Pilon 7 2 99.6% 7/7 51/51 
51_92 
MiSeq 66  99.5% 7/7 48/51 
MinION 1  21.6% 2/7 8/51 
Unicycler 1 1 99.6% 7/7 51/51 
Canu + Pilon 1 1 99.6% 7/7 51/51 
53_58 
MiSeq 90  99.6% 7/7 49/51 
MinION 24  17.2% 2/7 9/51 
Unicycler 22 3 99.6% 7/7 51/51 
Canu + Pilon 24 2 99.6% 7/7 51/51 
53_60 
MiSeq 66  99.5% 7/7 51/51 
MinION 1  17.2% 6/7 9/51 
Unicycler 1 1 99.6% 7/7 51/51 
Canu + Pilon 1 1 99.6% 7/7 51/51 
53_63 
MiSeq 91  99.5% 7/7 46/51 
MinION 29  10.3% 1/7 5/51 
Unicycler 29 16 99.5% 7/7 51/51 
Canu + Pilon 29 3 99.6% 7/7 50/51 
53_88 
MiSeq 69  99.6% 7/7 50/51 
MinION 5  16.8% 2/7 7/51 
Unicycler 5 1 99.6% 7/7 51/51 
Canu + Pilon 5 1 99.6% 7/7 51/51 
Assembly data for the four different assembly methods. Isolates 46_57 – 51_92 are canine isolates, 53_58 – 
53_88 are human isolates. Base MiSeq and MinION assemblies were not scaffolded as they were not to be used in 
endpoint analyses. 
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For sequence typing, the MinION assemblies had low yields of identifiable genes. The rest 
of the assemblies could consistently be identified as their expected MLST in all assemblies. When 
using rMLST to examine ribosomal S. pseudintermedius genes, MinION assemblies performed 
similarly poorly while MiSeq, Unicycler, and Canu + Pilon assemblies were all complete enough 
to identify the vast majority of genes. Four new alleles were identified, submitted, and assigned 
types resulting in 4 new rMLST profiles for S. pseudintermedius. 
As the most contiguous with high BUSCO scores, the Canu + Pilon hybrid assemblies were 
submitted to GenBank (Project accession PRJNA521119, genome accession numbers listed in 
Table 6) and used for the subsequent analyses. 
 
 
 
Table 6: Bacteremia Published Genome Data 
Isolate Source BUSCO 
(%) 
N50 Genome 
Size 
(bp) 
GenBank 
Accession 
SRA 
MinION 
Accession 
SRA 
MiSeq 
Accession 
46_57 Canine 99.20 638705 2561987 SEZZ00000000 SRR8538958 SRR8538959 
49_44 Canine 98.70 385638 2583863 CP035743 SRR8538960 SRR8538961 
50_21 Canine 99.60 1401107 2527337 SEZY00000000 SRR8538954 SRR8538955 
51_92 Canine 99.60 2512263 2512263 CP035742 SRR8538956 SRR8538957 
53_58 Human 99.60 238709 2655352 SEZX00000000 SRR8538952 SRR8538953 
53_60 Human 99.60 2615859 2615859 CP035741 SRR8538946 SRR8538947 
53_63 Human 99.60 191852 2628670 SEZW00000000 SRR8538948 SRR8538949 
53_88 Human 99.60 1396228 2593641 CP035740 SRR8538950 SRR8538951 
Characteristics and accession numbers of genomes of S. pseudintermedius bacteremia isolates published to 
GenBank. 
 
 
 
Virulence factors 
Virulence factors of the 8 bacteremia isolates are described in Figure 9. For biofilm 
production, 63% (5/8) were slime-producing, with 3/4 of the canine isolates and 2/4 of the human 
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isolates being slime producers. All of the isolates except 53-088 carried icaAD for slime-
production. All isolates except for the human isolate 53-088 were found to be non-adherent when 
examining overall biofilm production via CVA. 53-088 was weakly adherent.  
All isolates carried the toxin genes se-int, Luk-I, siet, and speta. None carried expB. The 
canine isolate 49-044 alone carried expA, while human isolates 53-060 and 53-088 both carried 
sec-canine. 
All isolates were MSSP, as determined by the lack of mecA. Only 49-044 carried 
aminoglycoside resistance genes (both ant(6)-Ia and aph(3')-III). All isolates except 53-088 
carried blaZ for β-lactam resistance, and both 53-058 and 49-044 carried tet(M) for tetracycline 
resistance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
62 
Figure 9. Characterization of Bacteremia Isolates 
Characteristics of bacteremia isolates organized by maximum likelihood phylogenetic tree. No significance was 
seen. 
 
 
 
Sequence typing, agr, and relatedness 
None of the bacteremia isolates were agr group I; 2 of the canine isolates and 1 human 
isolate were agr group II; 1 canine isolate and 2 human isolates were agr group III; and 1 canine 
and 1 human isolate were agr type IV. All 8 were unique MLST and they were also all unique 
rMLST (Table 7). The Newick phylogeny tree (Figure 9) suggests the 4 human isolates are more 
closely related to each other than any of the canine isolates, and vice versa. PHYLOViZ analysis 
(Figure 10) showed a more complex relationship when relatedness was based solely upon MLST 
and included all known STs submitted to the MLST database. 
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Table 7: Typing Characteristics of Bacteremia Isolates 
Isolate Source agr 
Group 
MLST rMLST Methicillin 
Resistance 
46_57 Canine II 815 65964 MSSP 
49_44 Canine IV 856 65100 MSSP 
50_21 Canine III 1335 102351 MSSP 
51_92 Canine II 865 65103 MSSP 
53_58 Human III 824 65109 MSSP 
53_60 Human II 879 65101 MSSP 
53_63 Human III 878 102352 MSSP 
53_88 Human IV 1045 102353 MSSP 
Mulitlocus sequence typing, agr group, and MRSP/MSSP status of bacteremia isolates. 
 
 
 
Figure 10: Phylogenetic Relationships of Bacteremia Isolates 
 
A complex phylogenetic tree showing the more complex nature of how canine (blue) and human (purple) isolates 
are related based on all known MLST (via PHYLOViZ). 
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Pan-genome analysis 
Pan-genomes represent the non-redundant genes present in a given dataset, consisting of 
the core genome (genes shared by all genomes in the dataset), accessory genome (absent in some 
genomes), and species- or strain-specific genes (present only in 1 genome). The core genome 
generally consists of genes involved in essential cellular processes, while accessory and strain-
specific genes are often involved with niche adaptation (110, 162).  
 
 
 
Figure 11: Roary Gene Clusters 
 
Roary output of gene groups shared between isolates, visualized by Roary_Plots. Isolates in descending 
order on the tree are 53_60, 53_88, 53_58, and 53_56 (human isolates); 46_57, 49_44, 50_21, and 51_92 (canine 
isolates). 
 
 
 
Pan-genomic analysis of the 4 canine isolates alone found a core genome of 2,107 genes 
with 724 shell genes (genes present in 15% - 95% of isolates) for a total of 2,831 genes. The human 
isolates had a core genome of 2,088 genes with 1077 shell genes for a total pan-genome of 3,165. 
When analyzed together, the core genome of the 8 bacteremia isolates consisted of 2,032 genes, 
with 544 shell genes and 930 cloud genes (present in 0% - 15% of isolates) for a pan-genome of 
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3,506 genes. The gene clusters shared between the isolates were visualized using Roary_Plots and 
can be seen in Figure 11, while the number of new and unique genes found in the genomes is 
visualized in Figure 12. The most common core genes were hypothetical proteins (n = 577).  
 
 
 
Figure 12: Core Gene Output 
 
Roary output of genes shared between isolates, visualized by Roary_Plots, demonstrating the high amount 
of core genes shared between them as a marked decrease (seen from moving from 1 genome to 2 genomes) of new 
and unique genes identified when analyzing each genome. 
 
 
 
The most common subsystem class of genes of the core pan-genome was metabolism, 
followed by protein processing, energy, and stress response, defense, and virulence. The subsystem 
distributions between human and canine isolates were similar (Figure 13). There were 2,487 genes 
found in both canine and human isolates, with 339 accessory genes found unique to the 4 canine 
isolates and 680 accessory genes unique to the 4 human isolates. Of these unique accessory genes, 
the majority (n = 306 for canine and n = 624 for human) were found in only 1 isolate from either 
group. From canine isolates, 24 genes were found in 2/4 isolates, 9 in 3/4 isolates, and none in all 
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4. From the human isolates, 52 genes were found in 2/4 isolates, 4 in 3/4 isolates, and none in all 
4. The majority of these genes were hypothetical proteins.  
 
 
 
Figure 13: Protein Subsystem Distribution 
 
 
Subsystem of human isolates (top) and canine isolates (bottom), produced by PATRIC’s Protein Family Sorter. 
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No major regions of difference between human and canine isolates were apparent using a 
proteome comparison (Figure 14). 
 
 
 
Figure 14: Proteome Comparison 
 
Proteome comparison of human and canine isolates when compared to reference strain ED99. While regions 
of difference were apparent between our 8 isolates and ED99, major regions unique to canine vs human were not 
observed. Figure adjusted from PATRIC’s Proteome Comparison Service. 
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For canine isolates, the 9 genes found in 3/4 isolates encoded 5 hypothetical proteins, a 
group II intron-encoded protein LtrA, an IS256 family transposase ISBsu2, a lipase, and a 
lactococcin-G-processing and transport ATP-binding protein. NCBI’s Blastp analysis showed two 
of these hypotheticals had 100% identity to two S. pseudintermedius group II intron reverse 
transcriptases/maturases (GenBank BBH74133.1 and PXA19680.1) and one was most closely 
identical (98%) to a bacteriocin found in another S. pseudintermedius (GenBank 
WP_110165491.1).  
 For genes found in 3/4 of the human isolates, 3 encoded hypothetical proteins and 1 
encoded a glycosyltransferase. NCBI’s BLASTP found that one hypothetical protein had 100% 
identity to a S. pseudintermedius trypsin-like serine protease (GenBank WP_037543863.1) and 
another had 100% identity to an IS110 family transposase (GenBank WP_096548892.1). 
No genes were found to be significantly associated with the source (human vs canine) of 
the isolates according to Scoary’s statistical analysis, with the Bonferroni adjusted P value. 
Similarly, no genes were found significantly associated with agr group given the small sample size 
of the groups (0 I, 3 II, 3 III, 2 IV), although several genes were identified with a significant naïve 
P value due to being carried in all isolates of the respective trait and none outside (or vice versa) – 
while not to be considered statistically significant, these are potential genes of interest.  
Of these, 4 genes were found only in agr group II isolates, which included the type II agrB 
allele and 3 hypothetical proteins (Blastp suggests these include agrC and agrD). Three proteins - 
agrB of other types and 2 hypothetical proteins suggested to be agrD alleles and a glutamyl 
endopeptidase - were found in all isolates outside of agr group II and none from group II. For agr 
group III a hypothetical gene was found in all 3 members of the group and none of the other 
isolates, and was suggested by Blastp to be the agrC III allele. Twelve genes of interest were found 
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in agr group IV; 2 genes found only outside group IV including a hypothetical protein and rbsD_2, 
a D-ribose pyranase found in all isolates outside of this group, and 10 genes found only within this 
group including 9 hypothetical proteins and an IS3 family transposase ISHahy5. Blastp analysis 
suggests the 9 hypothetical proteins include agrC and agrD of type IV, a nucleotidyltransferase, 
and an ATP-grasp domain-containing protein. 
No genes were significantly associated with overall biofilm production or slime 
production; however, one hypothetical protein was found in all slime-producing isolates and fnbA, 
the fibronectin-binding protein A, was found in all non-slime-producing isolates and none of the 
slime-producing isolates. 
 
Discussion 
The combination of MinION and MiSeq reads allowed for genomes to be assembled into 
accurate and highly contiguous assemblies. MiSeq assemblies alone result in highly accurate, but 
very fragmented assemblies, while using them in conjunction with MinION maximizes the benefits 
of long-read sequencing technology (fewer contigs) and compensates for higher error rate. 
Unicycler and Canu + Pilon hybrid assemblies both can result in similarly near-complete genomes 
per BUSCO. Unicycler is a single-input pipeline that requires far less time and effort to run, while 
repeated Pilon polishing and BAM generation is more time consuming. However, Pilon polishing 
retains the low contig number from the MinION assemblies. While Unicycler did reduce the 
contigs from the number in MiSeq assemblies, it did not manage to match the number from the 
original or polished MinION assemblies, even when run on Bold mode. While both hybrid 
assembly strategies have advantages, for more contiguous and still highly scored assembles, we 
found Canu + Pilon to be superior. 
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Pan-genome analysis of these genomes identified approximately 300 accessory genes 
unique to the canine isolates and 700 to the human isolates, although the vast majority were 
hypothetical proteins found only in 1 isolate from each group. Combined with the small sample 
size, there were only a handful genes that were of note as they appeared unique to each source 
group and in the majority (3/4) of isolates from that group. Most of these genes were involved in 
mobile genetic elements, with 3 of the 9 proteins found unique to canine isolates encoding group 
II intron proteins and 1 encoding a transposase, and 1 of the 4 proteins found unique to the human 
isolates being a transposase. Two more genes found in canine sourced isolates were related to 
bacteriocin carriage (1 suggested/uncharacterized bacteriocin and one gene encoding the 
bacteriocin lactococcin G processing and export protein). Of potential note was the unique carriage 
of a glycosyltransferase by three of the four isolates from humans. Prokka annotation attributed 
the gene to the Gtf1 family, members of which are required to export GspB, a protein that mediates 
binding of Streptococcus gordonii to human platelets (132), and homologues have been found in 
S. aureus and S. epidermidis strains (UniProtKB A0A0U1MTH8 and A0A0H2VKQ1). Blastp 
matches it 100% to a teichoic acid biosynthesis protein carried in a canine S. pseudintermedius 
strain of a different MLST (ST84, strain NA45, NCBI Protein Annotation # ANQ80832.1) and 
>99% to a glycosyltransferase carried in S. aureus. The clinical implications of the carriage of this 
protein are currently unclear and the carriage was not statistically significant within this sample 
collection, however it is worth investigating the carriage of this gene and the related system 
proteins in a larger selection of S. pseudintermedius isolates from human infections. 
Due to the small sample size, it is not surprising that few significant differences were found. 
Results of the Scoary analysis found no statistical significance in gene carriage between source or 
agr group with Bonferroni adjusted p values, although the program did identify genes that were 
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found only in certain agr groups, mainly their respective agrBCD alleles. Of potential interest was 
that the fibronectin-binding protein fnbA was only found in non-slime producing isolates and was 
in none of the slime-producing isolates, although 3/4 of the non-slime producing isolates carried 
ica operon for slime-production. Significant joint-carriage of fnbA and the ica operon has been 
seen in S. aureus (97), and a wide range of S. aureus isolates (40 - 80%) carry fnbA (3, 195), so 
this result is unexpected. As mentioned in previous chapters, ica expression and biofilm production 
is complex and subject to environmental conditions resulting in many ica-operon-containing 
isolates not producing slime and consequently reading as negative on CRA, while still producing 
biofilms via CVA. In this case, only 53-088, which lacked the ica operon, produced any overall 
biofilm on CVA. It is possible that the non-slime-producing isolates apart from 53-088 would 
produce slime in environments similar to in vivo colonization that were not tested in this study. 
Published literature has found higher carriage of fnbA in specific S. aureus infections, including 
auricular, orthopedic, endocarditis, and prosthetic hip and knee joint infections (3, 125, 137, 195). 
Given the small sample size, the implications of fnbA carriage only being seen in slime-negative 
isolates of bacteremia infections are unclear. 
 The pan-genomic analysis of these 8 genomes suggest that there is merit in analyzing the 
pan-genomes of larger sample sizes of isolates from human infections and canine infections, as 
differences are suggested even with this small sample size that cannot be fully elucidated without 
higher statistical power. As more human S. pseudintermedius infections are being identified, larger 
collections will allow for higher powered analysis that may be important in understanding the 
similarities and differences of S. pseudintermedius virulence and pathogenesis across these two 
species.  
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CHAPTER VI 
CONCLUSIONS 
 
 Staphylococcus pseudintermedius is an important pathogen causing skin and a wide range 
of infections in both canines and humans. As its recognition as a significant human pathogen is 
recent, far less has been elucidated regarding the pathogenesis and virulence of S. 
pseudintermedius as compared to S. aureus and S. epidermidis. Understanding the epidemiology 
of the agr operon, which is an essential component of virulence regulation, and its associations 
with different types of infections, resistance, and virulence factors, provides valuable information 
to microbiologists and clinicians. The agr operon is a promising target for alternative treatment in 
S. pseudintermedius as increased antimicrobial drug resistance in this species make treatment 
challenging. Alternative therapies are of particular interest as judicious use of antimicrobials in 
veterinary medicine prevents using antibiotics considered drugs of last resort in human medicine. 
There were three aims of this study focused on improving our understanding of S. 
pseudintermedius virulence, the agr system, and infections in canines and humans. The findings 
are summarized as follows.  
 
AIM 1: Measure biofilm forming capabilities of 710 S. pseudintermedius isolates 
collected from canines presenting with and without clinical disease to the VMTH, and 
classify them based on biofilm production. 
We measured both overall biofilm production (via CVA) and slime production (via CRA) 
in 710 clinical isolates from unique dogs. Approximately half of the isolates (51%, n = 362) 
produced slime in the tested conditions, with slime production being significantly higher in isolates 
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from diseased dogs (55%) compared to healthy (39%). The majority (88%) of isolates produced 
biofilm per CVA, with most (78%) producing weak or moderate biofilms while only 12% were 
found to be non-adherent. The presence of overall biofilm production in the majority of isolates 
highlights the importance of biofilm to staphylococcal colonization. The lower number of slime-
producing isolates, despite the fact that the vast majority of S. pseudintermedius isolates contain 
the ica operon for slime production, demonstrates the complex and highly regulated nature of 
biofilm production in these species. It is therefore important not only to perform a combination of 
phenotypical tests such as CVA and CRA, but to also take into account the genetics as well as 
conditions (nutrients, open systems, or microcosms) for testing isolates of interest. While these 
more involved biofilm assays and conditions can be impractical for large-scale characterizations 
such as the one performed here, biofilm production is too complex to be fully understood using 
the CVA and CRA assays alone.  
  
AIM 2: Complete whole-genome sequencing and assembly of 160 clinical isolates. 
Determine the agr type of 160 isolates collected from dogs presenting with surgical infections, 
pyoderma, urinary tract infections, and healthy dogs that presented to the VMTH. 
Determine the MLST of all clinical isolates sequenced. Determine whether agr type is 
associated with disease type, MLST, or biofilm production. 
 WGS and genome assembly of the 160 canine isolates of S. pseudintermedius allowed us 
to identify the MLST of all isolates, including 113 new strain types. Our phylogenetic analysis 
using PHYLOViZ suggested the major North American MRSP clonal complexes to be CC 45, 64, 
68, 71, 84, 150, and 155. This is the first time CC45 has been identified as a major group in the 
United States. The relationship between biofilm production (slime and overall) and MLST is, 
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unsurprisingly, complex, with ST71 previously being identified as the most slime-producing ST, 
while our study suggested it was significantly less associated with overall biofilm production while 
also being associated with surgical infections. These MRSP CCs were also all more likely to be 
MDR, but the majority of our isolates belonged to new ST groups and were MSSP. Due to a lack 
of resolution found using MLST, future studies should incorporate rMLST as the 53-gene scheme 
offers higher resolution of the relationships between STs and CCs.   
 The agr group of all 160 isolates was determined, with 11 isolates (7%) belonging to agr 
group I, 50 (31%) to group II, 44 (28%) to group III, and 55 (34%) to group IV. While the major 
MRSP STs are associated with a single agr group, agr groups were not associated with STs (i.e., 
all ST68 isolates are agr group IV, but not all isolates in agr group IV are ST68). The only 
significant association between agr group and disease group (healthy, pyoderma, urine, surgical) 
was that agr group II was more likely to be associated with healthy colonization rather than 
disease. No group had significant associations with overall biofilm production, although slime-
production was significantly more associated with agr groups I and IV compared to II and III. 
Group II isolates were also less likely to carry MLS resistance genes, tetracycline resistance genes, 
and trimethoprim resistance genes – and, overall, group II isolates were less likely to be MDR. In 
contrast, group IV not only had increased association with slime production, but also with 
trimethoprim resistance gene carriage as well as carriage of the exfoliative toxin gene expA and, 
along with group II, were more likely to carry the toxin gene sec-canine.  
 Further study is required with isolates from both more specifically defined infections and 
infections with graded severity to better clarify the relationships between agr group and infection 
type. Investigation of the four agr alleles and their ability (or lack thereof) to cross-interfere with 
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each other and the consequent clinical impact of agr interference will be an important next step in 
assessing possible therapeutic avenues targeting the agr system in S. pseudintermedius.  
 
AIM 3: Complete whole-genome assembly of 8 bacteremia isolates, four canine and 
four human, using a combination of long- and short-read sequencing technologies. 
Determine whether there are any describable differences between canine or human isolates 
regarding agr type, MLST, and virulence factors. 
 Four separate assemblies, including 2 hybrid assemblies, were performed for each isolate. 
The Canu + Pilon hybrid assembly was the most contiguous and scored approximately 99% for 
completeness via BUSCO, while Unicycler hybrid assemblies scored similarly high yet were far 
more fragmented. For our purposes of publishing complete (if possible) genomes, Canu + Pilon 
hybrid assembly proved to be the most successful.  
 There were no describable differences in agr type between human and canine bacteremia 
isolates, and they all had different sequence types. Seven of the eight isolates were found to be 
non-adherent without discernable biofilm formation, while one human isolate produced a weak 
biofilm. There were no clear differences in toxin carriage, slime production, or antimicrobial 
resistances between human and canine bacteremia isolates.  
 Interestingly, the Newick phylogeny tree generation suggests the human and canine 
isolates are more closely related to the others within their respective source groups, however this 
was not reflected in MLST phylogeny and may not be seen in a larger sample size. The pan 
genomes of the two groups did differ, mainly due to accessory gene carriage, but none of the gene 
differences were significant between human and canine genomes.  
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 The majority of the genes found unique to human or canine isolates that were seen in 3/4 
of the genomes were associated with mobile genetic elements. Statistical analysis of the pan-
genome via Scoary did not find any significant associations with human or canine source, but did 
find genes of interest associated with slime-production and agr type. This suggests that pan-
genomic analysis could provide valuable insight and find significant gene associations with 
characteristics such as those examined in Chapter IV, where a larger sample size would increase 
the statistical power. Further study is needed with a larger sample size of isolates to examine 
potential differences and genes of importance in human infections compared to canine infections.  
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